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ABSTRACT

The terminal alkyne is one of the most widely used chemical moieties in chemical
biology. Thanks to the relative absence of this functional group in biology, it has
become a widespread functional handle for a plethora of biorthogonal
chemistries. Our group has extended the scope of this functionality by developing
a biological variant of the Glaser-Hay coupling, which brings together two
terminal alkynes to form a diyne linkage. However, our initial findings revealed
that the chemistry is plagued by protein degradation due to a deleterious
copper(II) hydroxyl intermediate. Herein we extend the scope of the terimanl
alkyne be developing a biological variant of the Cadiot-Chodkiewicz coupling,
which brings together a bromoalkyne and a terminal alkyne to form a diyne
linkage. Unlike the Glaser-Hay, the Cadiot-Chodkiewicz is thought to be net
redox neutral. We found that this chemistry is biologically compatible and does
indeed reduce copper(II)-mediated cytotoxicity while increasing rates of diyne
formation. Finally, we extend our findings on diyne-forming chemistries by
applying this conjugation to a variety of projects, ranging from undergraduate
teaching labs, bioconjugate preparation, and protein function, thereby expanding
the scope of this conjugation strategy.
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CHAPTER 1: INTRODUCTION TO UNNATURAL AMINO ACIDS AND
BIOCONJUGATIONS

In the sequential arrangement of amino acids that form proteins, nature has
achieved elegant macromolecules with properties chemists have yet to fully replicate (see
Figure 1).1 Based on their biological functions, proteins can both bind small molecules
with incredibly high affinities and catalyze reactions with ease that often require harsh
conditions in vitro. Moreover, proteins have both synthetic and structural roles within the
cell, making them essential to life. Based on these characteristics, harnessing the power
of proteins would allow scientists to develop novel diagnostic and catalytic tools that
would advance science. Additionally, these unique properties of proteins make them
responsible for the myriad of cellular functions that enable living systems to exist. As
such, molecular biology has been revolutionized by the ability to study and observe
proteins in vivo. Thus, the study of proteins and their development towards novel
technologies is a crucial area of science that constantly requires additional innovations.

1

DNA

nucleotides
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Amino acids
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Aminoacyl tRNA synthetase
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Figure 1.The Central Dogma. DNA is comprised a triple nucleotide code, that is transcribed into RNA. This triplet
nucleotide code in the RNA is then translated into proteins via tRNAs that recognize the triplet code in the RNA. These
tRNAs are charged with the appropriate amino acid by aminoacyl tRNA synthetases.

Protein bioconjugates, in which a protein in conjugated to another molecule
(i.e.biomolecule, surface, fluorophore, therapeutic agent, etc), represent a broad area of
research with huge potential to impact basic science and medicine. For example, a serious
issue facing researchers wishing to fight cancer is discovering new ways to accurately
detect the presence of cancer within patients. A report in Nature detailed the use of
fluorescent probes as a means to live image cancer cells during surgery based on the
presence and detection of certain proteins.2 The results of such technology will enhance
removal of malignant tissue while decreasing relapse rates and damage to patient’s
healthy tissue. Accordingly, fluorescent molecular imaging is proving to be a key player
in the war against cancer, and while it has come a long way, there are limitations that
must be overcome before such specialized applications become widespread.
Another emerging field involving proteins is the development of protein biochips.
These biochips contain dense spots, or microarrays of thousands of diverse or
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homogenous proteins immobilized on a solid support.3,4 They offer the potential to
harness the unique power of protein chemistry. For example, such technology can allow
for the rapid and high-throughput screening of thousands of biologically interesting
molecules, allowing for the rapid discovery of new drug candidates. Similar to the Nature
paper previously discussed, such protein-based technology can be directly applied to
diagnostics, such as detecting cancer markers in blood.5,6 Due to their high affinity for
their substrate, protein chips would allow for the rapid and sensitive detection of
biomolecules and toxins.
Despite their promise, protein-based chips and protein conjugates are still a
nascent technology, being highly limited by current immobilization and conjugation
techniques. Many of these involve simple adsorption.4 In this technique, proteins are
adsorbed onto a surface via ionic or hydrophobic interactions. When performed on a
surface, the potential for multiple interacting sites often results in a heterogeneous layer
with a random protein orientation that may also be easily reversed. This is
disadvantageous, as the protein may not be correctly oriented to perform the desired
function. Covalent bonding to form protein conjugates is often the most ideal mechanism
to ensure an irreversible attachment. By reacting a functionalized partner with key amino
acid residues on the protein, such as lysine or cysteine residues that respectively contain
amine and thiol functionalities, more robust attachments can be made. However, these
covalent linkages on amino acids can occur at multiple sites, if more than one reactive
amino acid is present, resulting in proteins that may either be conformationally inactive
or also inappropriately oriented to bind molecules of interest.4 Bioaffinity based
attachment, in which key protein structures or properties (i.e. an antibody) are exploited
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to bind a high affinity ligand, is an option that can allow for the binding of proteins in
specific orientations. However, this technique relies on non-covalent binding, and is thus
less robust. Furthermore, it limits the number of proteins that can be bound to the surface,
since proteins must have particular structures or properties in order to interact with the
ligand.

Figure 2. There are numerous methods for immobilizing proteins on a solid support. Covalent attachment of the
protein represents the most robust technique, although it is often complicated by the presence of multiple reaction
partners on a single peptide. Adapted Rusmini et al.
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Before this biochip technology can become widespread, scientists must solve
these immobilization problems. Additionally, the need to find new ways to probe protein
structure and function also creates the need to develop new ways to manipulate protein
structure and function. A potential alternative to both of these areas involves the
application of unnatural amino acid technology.
Unnatural amino acids (UAAs) allow scientists to expand the rather limited
biochemical functionality found in the 20 canonical amino acids and introduce novel
reactivity not typically found in proteins.7,8 Incorporated via suppression of a TAG stop
codon in translation, which can be engineered into the DNA at a desired residue position
of the target protein, “chemical handles” can be introduced on the surface of the protein.
These functional handles then serve as sites of chemoselective reactivity. This strategy
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avoids the issue of multiple reaction partners on a single protein (which is typical when
trying to conjugate on a cysteine/lysine residue), and allows the chemist to access new
chemistries typically not available from the canonical 20 amino acids. Furthermore,
compared to the immobilization strategies discussed above, this technique opens up the
potential to exploit any protein that the chemist desires in a robust way.
Unnatural Amino Acids
Given the large number of functions proteins serve within an organism, as well as
the myriad of ways in which they could be combined, it is reasonable to assume that
evolution would have dictated the need for amino acids with diverse functional groups.
However, a quick glance at the natural 20 amino acids reveals only four main chemical
functionalities: nonpolar, polar, acidic, and basic.8,9
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Figure 3. There are 20 naturally occurring amino acids. Only five elements are represented in the canonical amino
acids, as well as a very limited set of chemical functionality. Adapted from chemwiki.ucdavis.edu

Advances in chemical biology have led to the development of UAAs that can be
synthesized with novel biochemical properties not available in the 20 canonical amino
acids. Such syntheses are relatively simple, as amino acids can be purchased with their
carboxyl and amino ends masked with protecting groups. The result is a selectively
reactive R-group that can be chemically modified. In particular, my research has focused
on derivativizing the amino acid tyrosine (Tyr) that has a phenol functionality that can be
activated by the addition of base. The deprotonated hydroxyl group can then undergo
nucleophilic substitution reactions with molecules that possess good leaving groups. The
result is a UAA that can serve as a starting point to introduce a myriad of novel
biochemical functionality into proteins.
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Figure 4. Unnatural amino acids allow chemists to access novel functionality and elements not present in the 20
canonical amino acids.

Generation of an Unnatural Amino Acid-Containing Protein
While the synthesis of UAAs is feasible, in order to capitalize on this technology
it is necessary to be able to introduce these UAAs into proteins of interest. Methods have
been developed to site-specifically incorporate these UAAs into proteins via insertion in
response to a TAG stop codon in the genome, giving researchers very precise control
over the placement and number of these UAAs in a protein’s amino acid sequence.8
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Early methodology relied on incorporating UAAs in vitro. By utilizing cell-free
protein assembly machinery, researchers were able to incorporate unnaturals into specific
sites of the protein via a nonsense codon. The associated tRNA for this nonsense codon
was then chemically aminoacylated with the UAA of interest. The result is a system that
ensured the incorporation of the UAA into a single, predefined residue of the
polypeptide. In particular, the amber suppressor codon (TAG) was typically employed, as
its frequency in the Escherichia coli genome, the organism of choice for many protein
expressions, is relatively low. This ensures the incorporation of a single UAA into a
single site.10,11 While this approach allowed for the site-specific incorporation of a UAA
into a protein’s primary sequence, the use of in vitro technology has serious limitations.
Many proteins require the aid of additional proteins in vivo before they can acquire the
correct conformation. As such, while this technique is ideal for the preparation of small
peptides, polypeptides may not be able to be generated in a robust manner. This severely
limits the biological applicability of UAAs. Furthermore, the synthesis of mutated
proteins in vitro limits the use of this technology beyond biochemical studies. For
example, novel methods of protein imaging in vivo could not be developed since this
technique required cell-free machinery.
An alternative strategy for UAA incorporation that allowed for the in vivo
incorporation of UAAs involved the complete replacement of a particular amino acid in
the organism’s proteome with a UAA (see Figure 5). In this non-site specific UAA
incorporation technique, the canonical amino acids methionine, leucine, isoleucine,
phenylalanine, tryptophan, or proline are replaced by an amino acid that resembles these
amino acids in structure.12 Typically, cells transformed with a protein of interest are
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grown in media containing all 20 amino acids, pelleted, to remove the media prior to
protein expression. Upon the induction of protein expression, the cells are resuspended in
a new media that lacks one of these canonical amino acids. In place of the amino acid, an
unnatural amino acid is included in the broth. By synthesizing amino acids that resemble
the removed amino acid, scientists can trick the cell into incorporating their UAA in
place of the canonical amino acid in the protein of interest. Tirrell and Finn demonstrated
the utility of this approach by synthesizing methionine analogs. In place of the thioether
functionality, the group included azide and alkyne functionalities in their UAAs. As a
result, they were able to demonstrate that in place of methionine, E. coli expressing a
bacteriophage protein capsid could generate capsids labeled with either the azide or
alkyne functionality in the residues that were originally methionine. While this approach
also allows researchers to incorporate UAAs in a semi-site specific fashion, the frequency
of UAA placement in a protein can be highly variable, due to the redundancy inherent in
the 20 amino acid lexicon. The result can be complete dysfunction of the protein if the
presence of multiple UAAs alters the protein’s structure too much. Additionally, this
technique impacts the organism’s proteome, introducing the UAA in place of the
canonical amino acid in every protein expressed. The result could be highly deleterious
for the organism, which is not beneficial for in vivo applications.12
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B.

UAA-containing
protein

Natural scenario – 1 canonical amino acid

Unnatural
amino acid

Figure 5. Whole cell replacement of a canonical amino acid with a synthetically similar analogue (UAA). The resulting
cell incorporates the UAA in place of the canonical amino acid throughout its entire proteome, resulting in UAA
incorporation in a non-specific manner. Adapted from
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Since these early in vitro studies, more recent work has focused on generating
technology that would allow for the in vivo incorporation of UAAs. Additional
challenges come into play when considering such techniques. First, as mentioned above,
the incorporation of the UAA must be site specific, and it must occur only in the residue
sites that have been previously determined by the researcher. Should the UAA be
incorporated into additional non-specified sites, the result could be inactivation of the
protein of interest, or subsequent death of the organism. Additionally, the tRNA
machinery employed must act solely on the UAA of interest. By translating unnatural
amino acid technology towards in vivo incorporation, the added problem of having to
deal with three elements arises: the UAA, the tRNA, and the aminoacyl-tRNA synthetase
(aaRS) that is responsible for charging the tRNA with the UAA. In order for successful
incorporation to occur, the aminoacyl-tRNA synthetase should only pair with the UAA
and with the corresponding suppressor tRNA. Should this orthogonality to the
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endogenous translation machinery not be maintained, endogenous amino acids could be
incorporated into proteins in place of the UAA and vice versa. Finally, the UAA must be
cell permeable and non-cytotoxic in order to be incorporated.8,14

Figure 6. Mechanism for genetic incorporation of unnatural amino acids. An orthogonal synthetase must be
introduced that does not cross-react with any natural tRNA or amino acid. This is coupled with a new tRNA that
harbors an anticodon for the TAG codon. When the ribosome encounters the TAG codon, a new amino acid is
incorporated, rather than the discontinuation of translation. Adapted from Chem. Biol. 2009 16, 323-336.

Early studies with E. coli models attempted to evolve an endogenous tRNA
synthetase/tRNA pair that was orthogonal to a UAA of interest utilizing E. coli’s
translational machinery. However, such tactics were wrought with misaminoacylation,
and subsequently terminated.15 Instead, researchers focused on examining the protein
translation machinery of other organisms, which would not interact with the endogenous
aaRS/tRNA pairs in E. coli. In vitro studies found that a tyrosine aaRS/tRNA pair from
the archaea M. jannaschii was the first of such pairs used to successfully incorporate a
Tyr in response to a TAG stop codon in a manner completely orthogonal to the host E.
coli’s translational machinery.16
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With acceptable aaRS/tRNA machinery from M. jannaschii in hand, researchers
next focused on a means to alter the specificity of the pair to recognize different UAAs.
This was done through a double-sieve selection method. First, a library of tRNA
synthetases was constructed based off the Tyr-aaRS of M. jannaschii. Within this library,
five to six residues within the binding site of the aaRS were genetically mutated to be one
of the 20 amino acids, generating a library size on the order of 106 to 107 mutant aaRS.
This library size is still viable for conventional double transformation procedures. Next,
the library underwent a positive selection. In this step, E. coli were co-transformed with
the library of mutated synthetases and an enzyme encoding for a mutatedchloramphenicol degrading enzyme that contained an early TAG residue. Following
double-transformation, the transformed cells were grown on a plate in the presence of a
novel UAA and chloramphenicol. Survival implied the organism was able to use the
foreign aaRS machinery to charge the suppressor tRNA and thus produce a functional
chloramphenicol degrading enzyme.17 However, suppression does not guarantee that the
aaRS charged the suppressor tRNA using the UAA, as canonical amino acids could also
have been recognized by the aaRS and charged to the tRNA. As such, those cells that
grew were then isolated, their plasmids purified, and the remaining plasmid library was
then transformed for a negative selection. In the negative selection the toxic barnase gene
was employed. Barnase is a bacterial ribonuclease, and will degrade cellular RNA,
preventing protein synthesis and leading to cell death. The gene was mutated to harbor
three stop codons, and grown in the absence of unnatural amino acid. If the organism can
use the exogenous aaRS/tRNA pair to charge endogenous amino acids and suppress the
three TAG stop codons, it will produce the barnase protein and die.17 Thus, the end of
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this two round protocol selected for organisms that possessed an aaRS that could
selectively incorporate the UAA to some degree. By iterating this process for multiple
rounds with the UAA of interest, it was possible to evolve an aaRS/tRNA pair that works
selectively for the UAA of interest. This is the evolution procedure used today for in vivo
incorporation of UAA. These site-specifically incorporated UAAs can now serve as
functional “handles” for the development of new protein conjugates.

Figure 7. General scheme for the selection of an aminoacyl-tRNA synthetase that recognizes and incorporates a
specific unnatural amino acid.

Biorthogonal Chemistry
A growing area of interest in chemical biology is the ability to perform chemistry,
particularly conjugation reactions, within living systems. In order for such chemistry to
be feasible though, certain conditions must be met by the chemical reaction employed.
Most importantly, the chemistry must be biologically chemoselective, and not interfere
with any endogenouse biological processes. Furthermore, the reaction must proceed at
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relatively rapid rates under physiological conditions (typically at 37°C and ~pH 7) as
well as being inert to the myriad of functionalities encountered in biological systems.18
Should the above conditions be met, the chemistry is deemed bioorthogonal.
However, when considering the numerous functionalities found within living systems, as
well as the limitations of concentrations and temperatures, the task of identifying
bioorthogonal chemistries seems daunting.

Cu(I)-1,3-dipolar Cycloaddition or Cu(I) “Click” Chemistry
Click chemistry, a subset of reactions that can proceed to completion in relatively
mild conditions to produce a single product with minimal to no side reactions, has
emerged as a means for performing bioorthogonal chemistry. In particular, the [3+2]
cycloaddition of azides and alkynes, termed a Huisgen-1,3-dipolar cycloaddition, has
flourished as a means to tackle the complexity of bioorthoganlitity.19 Not only do these
reactions produce a stable, covalent triazole moiety, thus ensuring efficient and stable
conjugation between the two functionalities in vivo where bonds may readily decompose,
but the azide and alkyne functionalities are also absent from biological systems.
Furthermore, the two molecules react selectively with each other, thus side-reactions with
other biological molecules is not a concern. Thus, the 1,3-dipolar cycloaddition using
azides and alkynes has the potential to be an optimal chemistry for the development of
bioconjugation reactions. However, the initial reaction reported in the early 20th century
required temperatures upwards of 98°C in order to achieve useful reaction rates, well
above the temperature range of physiological viability.19
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The viability of this chemistry was restored when the Sharpless and Meldal
groups concurrently, yet separately, developed a copper(I) catalyzed variant of the
cycloaddition.20,21 Reduction of copper(II) to copper(I) in the presence of a terminal
alkyne allows for the formation of an activated copper acetylide intermediate, which has
an increased reactivity with azides to form the traizole ring product. This coppercatalyzed azide-alkyne 1,3-dipolar cycloaddition (CuAAC) exhibited an increased
reaction rate of seven orders of magnitude, as well as being capable of reacting at room
temperature and even 4°C.22 The fact that the reaction can be made even more favorable
by the addition of tetradentate ligands, such as tris[(1-benzyl-1H-1,2,3-trizol-4yl)methyl]amine (TBTA), that help stabilize the copper(I) catalyst resulted in this
chemistry rising to the forefront of bioconjugation reactions.23
Scheme 1

While the CuAAC reaction afforded desirable temperature ranges and reaction
rates, it possessed a single hindrance to its use in biological systems. The reaction’s
dependence on copper was ultimately its greatest flaw, as copper is cytotoxic to most
organisms. Bacterial cells have been shown to halt cell division following exposure to
100 µM CuBr, and mammalian cells can only endure very low concentrations of copper
(below 500 µM) for 1 hour.18 As such, the Bertozzi group sought to develop a copper free
variant that may proceed with similar favorability by capitalizing on strained ring
systems. In particular, cyclooctyne, the smallest ring that can contain a triple bond, was
used to activate the alkyne towards the cycloaddition via strain. The result was a
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cycloaddition, however, the reaction proceeded at rates considerably slower than
CuAAC.24 By addition of electron withdrawing fluorines, the Bertozzi group was able to
generate a difluoronated cyclooctyne (termed DIFO) capable of undergoing copper free
click reactions at rates comparable to CuAAC. Thus, the cycloocctyne reagent is nontoxic
and can be derivitized to include additional functionalities, such as conjugated fluorescent
moieties.25
Scheme 2.
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The CuAAC and the strain promoted azido-alkyne cycloaddition (SPAAC) both
serve as useful reactions for the bioconjugation of proteins bearing UAAs with other
molecules. Because the placement of UAAs within a protein can be site-specifically
controlled, UAAs can be inserted into proteins in unique residues that minimize changes
to the protein’s folding while allowing for maximal exposure of the UAA. These surface
exposed residue sites allow for UAAs to serve as unique biochemical handles for the
targeted promotion of these bioconjugation reactions. UAAs synthesized with azide or
alkyne functionality can be correspondingly clicked to another molecule bearing the
appropriate cognate handle. Such strategies allow for the directed control of
bioorthogonal chemistry towards proteins of interest.
Indeed, both CuAAC and SPAAC have already begun to receive attention as
novel methodologies to probe biological systems. Research on intracellular pathogens is
often complicated due to the difficulty of probing the pathogen in their endosomal
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environment.26,27 Methods such as antibody labeling are complicated by the need to pass
through multiple membrane structures. As such, Siegrist et al. demonstrated that UAA
analogs of D-alanine, which harbor an alkyne functional group, can be used to probe
peptidoglycan dynamics of intracellular bacterial pathogens in vivo, a technique that was
not previously accessible using more traditional antibody labeling approaches.26 In
particular, the authors demonstrated that the incorporation of the alkyne or azide
derivitized D-alanine UAAs allowed the researchers to perform CuAAC reactions using
the orthogonal probe on a fluorescent dye. Because the

D-alanine

analogs are used

exclusively by bacteria in the synthesis of their peptidoglycan layer, the researchers were
able to label intracellular pathogens, such as Listeria monocytogenes, in an in vivo
infection model and then observe peptidoglycan dynamics in real time.

Biorthogonal Transition Metal Chemistry
Many transition metal cross coupling reactions are biorthogonal, as the reactive
groups and metals involved are not found in biological systems. While limitations include
the toxicity and oxidative damage induced by the use of the transition metal, as well as
the prohibitive costs, overall these technologies are proving to be viable bioorthogonal
reactions. Through the use of 3-mercaptopropionic acid (3-MprAc) as a small and
effective palladium scavenger, Spicer and Davis were able to utilize p-iodophenylalanine
(pIF) to allow for introduction of an aryl halide for Suzuki-Miyaura cross coupling.28–32
This chemistry was then employed for the installation of hydrophobic groups on the
surface of a protein without requiring organic solvents or denaturing conditions. Full
conversion of the protein substrate was achieved and is notable when compared to the 2%
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and 25% conversion achieved via the Heck reaction and Sonogashira coupling
respectively.32 This technology was also used to tag porin channels via OmpC protein
monomers on the outside of cell surfaces. Using a fluorescent boronic acid as a label and
by measuring fluorescent intensity, a dramatic increase in labeling via Suzuki-Miyaura
coupling was achieved once a threshold concentration of 300 µM of Pd was utilized.31 A
corresponding Suzuki coupling has been performed with the boronate-containing UAA;
however, this reaction required both a high temperature (70 oC) and a high pH (8.5), thus
requiring further optimization.33

Figure 8.Labeling of pIF-containing OmpC using a fluoroescnet boronic acid via a biological Suzuki coupling.

Another palladium-based bioothogonal chemistry is the Sonogashira cross
coupling reaction. It was recently reported that an alkyne encoded ubiquitin was
employed to facilitate the attachment of aryl or vinyl containing groups.34 The reaction
reached completion in 30 minutes and did not occur in the absence of the palladium
catalyst, demonstrating the efficiency and Pd-mediated regulation of the reaction. This
coupling has been accomplished via the incorporation of a variety of UAAs including pIF
and lysine derivatized with an alkyne and iodo handle.34,35
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Figure 9. Surface labeling of E. coli using a an alkyne containing UAA in the presence of an iodo containing fluorogenic
dye via the biological Sonogashira coupling.

Though palladium mediated reactions that alter cell-surface functionality are
biologically viable at low levels of palladium, intracellular use of this reaction is limited
by the differing effects of palladium within the cell. Therefore, optimizing such reactions
for intracellular purposes can broaden the scope of such bioorthogonal chemistries.
As such, a recent report developed a Pd-mediated intracellular bioconjugation
employing lysine-derivatized UAAs containing either an alkynyl or aryliodo
functionality. These UAAs were readily incorporated into intracellular gram negative
bacterial proteins in vivo using an evolved pyrolysine tRNA synthetase/tRNA system. In
the presence of a simple Pd(NO3)2 catalyst, the authors were able to show efficient
intracellular conjugation of a dye at room temperature (25℃) within 40 mins.
Furthermore, the use of this Pd-catalyst was biocompatible, with neglible cytotoxicity at
concentrations below 200µM.35

Development of a Biological Glaser-Hay Coupling
As demonstrated by the CuAAC, SPAAC, and the transition metal chemistries
above, it is apparent that reactions involving terminal alkynes are advantageous for use in
biological systems due to the relative absence of triple bonds within these systems. The
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Glaser-Hay coupling is a reaction that involves conjugating two terminal alkynes via a
copper catalyst to afford a conjoined diyne product36,37 Salts of copper(I) are typically
used as the catalyst, and it has been proposed that the copper(I) complexes with the
terminal alkyne, activating the functionality towards the formation of a carbon-carbon
bond with another terminal alkyne.38,39
Scheme 3.

The coupling of terminal alkynes was first described by Carl Glaser in 1869.36
However, the reaction was not suited for biological settings. Glaser’s initial reaction,
however, involved an explosive copper(I)-phenylacetylide catalyst that required tedious
isolation following the reaction.36 Then, in 1962, Allan Hay published results using the
bidentate ligand N,N,N’,N’-tetramethyletheylene diamine (TMEDA) in conjunction with
the copper catalyst. This methodology improved reaction times, reduced temperature
requirements, and reduced the amount of copper necessary to allow the reaction to
proceed.37 It is proposed that the bidentate ligand TMEDA stabilizes the Cu(I) species,
opening up the complex to favor addition of the activated alkyne species to one end of the
copper species.38,39 The Glaser-Hay reaction today, in which a Cu(I) salt in the presence
of TMEDA in an organic solvent is added to two terminal alkynes, allows for the rapid
and facile synthesis of conjugated diynes. Furthermore, recent work has demonstrated the
reaction can proceed in good yield under biological temperatures (4℃ to 37℃), and has
enhanced reaction rates.40 While little work has been done to take advantage of these
unique features of this chemistry, these characteristics make the Glaser-Hay coupling
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ideal for the utilization of the bioorthogonal alkyne moiety for bioconjugation
applications.

Conclusion
UAA-mutagenesis technology allows the researcher to create site-specific
functional “handles” on proteins of interest. Herein we propose applying UAAmutagenesis for the development of novel biorthogonal chemistries, biological probes,
protein technologies, and immobilization techniques. In particular, employing the
terminal alkyne moiety throughout our studies to further expand the scope of its role in
chemical biology. By combining this technique with bioorthogonal chemistries, we hope
to manipulate biological systems and proteins in new ways that can further advance basic
science and medicine.
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CHAPTER 2: SYNTHESIS AND INCORPORATION OF UNNATURAL AMINO
ACIDS TO PROBE AND OPTIMIZE PROTEIN BIOCONJUGATIONS

Multiple techniques exist for the introduction of UAAs that range from completely
synthetic to completely biological via exploitation of endogenous translational
machinery.(20-22) The evolution of orthogonal aminoacyl-tRNA synthetase/tRNA pairs
has found a wide degree of success both in bioconjugations and various other
applications.(22) Specifically, several examples of the use of unnatural amino acids to
generate well defined bioconjugates including the reaction of an azide containing
calmodulin onto carbon nanotubes and nanoparticles via the Staudinger-Bertozzi
ligation,(23, 24) the immobilization of other proteins to M-20 Dynabeads in a cell-free
system with a click reaction,(25, 26) and the labeling of proteins with an agarose resin
and azido UAA for secretome MS analysis; (however, in this case the UAA was not sitespecifically incorporated into the pool of proteins).(27) More recently, we demonstrated
the optimization of protein immobilization utilizing an incorporated azido UAA,
conferring increased stability to organic solvents.(28) The combination of these studies
demonstrates the utility of site-specific bioconjugations, and the stabilizing benefits of the
solid support. Other studies have used similar techniques to label proteins with molecular
probes or generate novel therapeutic bioconjugates, demonstrating the wide applicability
of site-specific bioconjugations. (4, 29) Given the power of this technology, we aimed to
expand the utility of UAA bioconjugations through the alteration of the reactive UAAs to
optimize reaction parameters.
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Initial investigations attempted to further utilize UAAs to optimize bioconjugations
through several different bioorthogonal reactions. Our previous studies immobilizing
GFP demonstrated that the UAA residue location within the protein dictated its
immobilization efficiency.(28) Thus, the spatial configuration of the UAA handle is vital
for its reactivity with its conjugation partner. While it is possible to alter where the UAA
can be incorporated, this requires extensive genetic manipulation. An alternative
approach is to simply vary the distance of the UAA reactive group from the protein’s
surface. By extending the distance from the protein, the handle is less hindered by the
protein’s steric bulk, which may increase its propensity to react with its orthogonal
partner. Moreover, removing the reactive partner from conjugation with the aromatic ring
of the phenylalanine moiety may alter its chemical reactivity. Thus, it becomes important
to ascertain the ideal distance of the functional handle from the protein for efficient
reactivity. In order to probe novel bioorthogonal reactions utilizing UAA technology, a
variety of UAAs with new functional groups were synthesized and designed with variable
tether lengths to separate the reactive species from the bulk of the protein. These groups
included an azide, an alkyne, and a bromide respectively, all of which can be derived
from a modified tyrosine (Scheme 1). These functionalities afford access to the Cu(I)catalyzed 1,3-dipolar cycloaddition, the Glaser-Hay coupling, and a nucleophilic
substitution respectively.

Results and Discussion
To optimize the immobilization process, UAAs were synthesized with varied methylene
units extending from a tyrosine precursor. Derivatives containing 2, 3, and 4 methylenes
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of the azide, alkyne, and bromide functionalities previously mentioned were readily
accessible via a SN2 reaction (Scheme 1).
Scheme 4.

Synthesis of the nine UAAs began from a common N-Boc-OMe protected tyrosine
precursor. The goal was to synthesize a bromotyrosine derivative via a substitution
reaction with either dibromoethane, dibromopropane, or dibromobutane. These bromotyrosines (1-3) would then possess alkyl chains of varying lengths, and a good leaving
group for future reactions. Then, a secondary SN2 reaction with either an azide (4-6) or
alkynyl nucleophile would install the desired novel reactivity to the tyrosine derivatives.
However, synthesis of the alkynyl-tyrosine series proved more difficult than initially
anticipated, and the series was prepared directly via SN2 reactions commercially available
with bromo-alkynes (see Experimental).
Initial reactions between the protected tyrosine and the dibromobutane in
dimethylformamide (DMF) yielded the desired tyrosine derivative 3. However, reactions
involving the dibromopropane and dibromoethane in DMF did not proceed as expected
towards the desired tyrosine derivatives 1 and 2 respectively. Instead, starting material or
the alkene tyrosine derivative, the product of an elimination reaction, was obtained for
both reactions.
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Scheme 5.

Initially, the concern was that the DMF was not dry, and the presence of water in
the solvent may have led to increased elimination of the bromide. However, switching to
dry solvent systems did not improve the reaction, nor did it reduce the amount of
elimination product obtained. To optimize the reactions, we attempted adding a catalytic
amount of potassium iodide to both the dibromopropane and dibromoethane reactions.
The iodide can serve as a catalyst in this nucleophilic substitution, replacing the bromine
with iodine, a better leaving group, thereby facilitating the SN2 addition by the phenolate
of tyrosine. However, only starting material was recovered from these reactions, even
when reaction times and temperatures were varied. Ultimately, a literature search
revealed a similar compound had been successfully prepared using acetone as the solvent
system.37,38 Thus, all three reactions were attempted in acetone, with greater success. All
three bromotrysoine derivatives were successfully synthesized using acetone as the
solvent in the presence of base and potassium iodide as a catalyst. We hypothesize that
the additional polar amine functionality in the DMF allowed for increased solventmediated stability of the free bromine via dipole-dipole interactions following an
elimination reaction. Thus, DMF aided in the formation of the eliminated product.
Furthermore, electronics are clearly involved, as the shorter the alkyl chain became, the
closer in proximity the large, electronegative bromine groups were, increasing the
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propensity to eliminate. This was observed by a higher rate of elimination product using
dibromoethane when compared to dibromopropane. The use of acetone, a less polar
solvent, decreases the solvent-mediated dipole-dipole interactions with the free bromine,
and thus disfavors the elimination reaction. This was observed as the bromotryosine
derivatives were able to be successfully synthesized under these modified conditions.
Once the bromotyrosine compounds 1 to 3 had been synthesized, they were then
divided and reacted with either sodium azide or propargyl alcohol. Reaction with sodium
azide in DMF resulted in a nucleophilic substitution reaction between the azide and the
bromotryosine, affording the azidotyrosine derivatives 4 through 6 following silica gel
purification and NMR confirmation. The rest was reacted with propargyl alcohol in DMF
in order to perform a nucleophilic substitution between the hydroxyl group and the
bromotyrosine, resulting in the formation of the alkynyltyrosine products.
The alkyne-derivitized tyrosine series was not successfully synthesized under
these conditions (see Scheme 3), and instead yielded either the previously described
elimination product or the starting material.
Scheme 6.

Initially, potassium tert-butoxide (pKa ~17) was used as the activating base in the
reaction. We hypothesized that the propargyl alcohol (pKa ~13.6) may not be fully
deprotonated under these conditions, perhaps reducing the overall yield of the reaction.
As such, a small amount of sodium hydroxide was used as the activating base with little
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success. Ultimately, due to the inability to obtain derivatized tyrosine product, an
alternative synthesis strategy was adopted. Reaction of 4-bromo-1-butyne and 5-bromo1-pentyne with protected tyrosine in acetone with a catalytic amount of potassium iodide
was allowed to progress overnight (see scheme 1). Following column chromatography,
the desired alkyne products 7 and 8 were obtained, with the proper length alkyl chains
(either 3 or 2 methyl) for proper comparison to the azido- and bromo- derivatives of
similar lengths. In addition, 6-bromo-1-hexyne could be readily synthesized by reacting
6-hydroxy-1-hexyne with phosphorus (III) bromide (Scheme 4), followed by immediate
reaction with the protected tyrosine in acetone. Again, following column chromatography
the desired compound 9 was isolated.
Scheme 7.

The syntheses described above afford the derivatized tyrosines still harboring protecting
groups. To prevent reactivity of the amino group of the amino acid, an acid labile tertbutyloxy (Boc) group was employed. Additionally, to protect the carboxylic acid
functional group of the amino acid backbone, a base labile methyl ester was used.
Successive stirring in 1M lithium hydroxide to remove the methyl ester and 50% TFA in
DCM to remove the Boc group, afforded the nine deprotected UAAs in moderate overall
yields (see Table 1).
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Table 1. Overall Yields for Tethered UAA Syntheses

Typically with the new synthesis of UAAs a unique aaRS must be evolved to recognize
and incorporate the UAA; however, based on the previous demonstration of the
promiscuity of the pCNF-aaRS in E. coli,(30, 31) it was our hope that the structural
similarity of the nine prepared UAAs could facilitate incorporation without the need of a
double sieve aaRS selection. With respect to the bromo-derivatives, a previous report
used a similar approach to their incorporation in mammalian cells.(32, 33) Based on our
earlier studies we employed green fluorescent protein (GFP) as a model protein for
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incorporation due to its well-documented fluorescent properties facilitating rapid
visualization and quantitation. Our previous findings indicated that residue 151 conferred
the best conjugation efficiencies, and was thus selected for this study.(28) BL21(DE3) E.
coli were co-transformed with pEVOL-pCNF-aaRS and pET-GFP-151-TAG plasmids to
introduce both the GFP protein and the translational machinery necessary for TAG
suppression with UAAs. Following protein expression (30 oC, 16 h) in the presence or
absence of the UAA, cells were lysed and GFP was purified via Ni-NTA chromatography.
Gratifyingly, the application of the polyspecific aaRS was successful, as the nine UAAs
were able to be incorporated into GFP, albeit with differential expression levels (Table 2).
The incorporation of the UAA was visualized both by fluorescence and SDS-PAGE
analysis. As the pCNF synthetase was evolved to recognize pCNF, it was hypothesized
that the p2yneY-, p3yneY-, and p4yneY-UAA series would be most easily incorporated
due to the structural similarity between the cyano group and alkyne group in size and
polarizability.
Table 2. Protein Expression Yields for the Tethered UAAs
H 3N

COOH

O

X
n

X
Br

n

N3

C CH

1

0.704 mg/mL

0.347 mg/mL

0.702 mg/mL

2

0.291 mg/mL

0.685 mg/mL

0.767 mg/mL

3

0.277 mg/mL

0.246 mg/mL

0.447 mg/mL
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This result was observed, with the p3yneY (n = 2) producing a larger quantity of mutantGFP, and the p4yneY producing the lowest quantity of mutant-GFP within the alkyne
series. These qualitative observations were in accordance with our predictions based on
the evolution of the synthetase. We hypothesize that the increased tether distance may
have more difficulty fitting into the binding pocket of the tRNA synthetase relative to
smaller derivatives, preventing the UAA from being incorporated into the polypeptide
chain. Thus, a tradeoff may exist between the advantages of distancing the functional
group from the core of the protein and the reduced protein yields of these same
compounds. This trend was observed for all of the UAAs, as the tether length increased,
the expression yield decreased. However, all 9 UAAs were capable of being incorporated
using a single aaRS, not only obviating the necessity of a tedious selection, but also
increasing the versatility of this approach as only a single cotransformation is required to
produce 9 different UAA-containing proteins.
Given the ability to incorporate 3 different functionalities with variable tether lengths into
GFP, we next sought to employ these new UAAs in bioorthogonal conjugation reactions.
Studies were initiated with the azido-GFP series, as the cycloadditon reaction is one of
the most common and well-understood bioorthogonal reactions. Moreover, the various
tethers could be directly compared to the commonly utilized p-azidophenylalanine
(pAzF) that has no methylene tether and contains the azido group in direct conjugation
with the aromatic ring. We hypothesized that in addition to providing distance between
the protein and the conjugation partner, the removal of the azido conjugation may also
alter its reactivity. The various azido-containing GFP mutants were conjugated with a
fluorescent Alexafluor 488 alkyne dye using a CuSO4/TBTA/TCEP catalyst system based

33

on previously reported conditions.

40,41

Gratifyingly, all tethered derivatives could be

conjugated to the dye, as determined by both fluorimetry and SDS-PAGE analysis
(Figure 1). Control reactions were also performed in the absence of catalyst system to
ensure that protein labeling was not due to non-specific reactions or non-covalent
association by the dye. These controls yielded no fluorescent product following protein
denaturation, and thus indicated that any fluorescence is indeed a result of the coupling to
form the triazole ring. Interestingly, the p3AzY handle appears to have the best
conjugation efficiency, compared to the more sterically hindered p2AzY and the more
flexible p4AzY handles (Figure 1).

Figure 10. Expression and conjugation of GFP-151 mutants with an AlexaFluor488 dye. The Coomassie stained gel
(top) indicates the successful incorporation of all three azides in the series as an appropriate band is observed for GFP
at ~26 kDa. The fluorescence of the same gels (bottom) indicate each azido-GFP mutant also was able to undergo a
successful bioconjugation with an AlexaFluor-488 alkyne. No coupling was observed in the absence of copper catalyst
despite the inclusion of the fluorophore alkyne, as no fluorescence is detected in the absence of catalyst.

With successful bioorthogonal reaction conditions in hand, we next sought to apply the
chemistry for immobilization purposes. As mentioned previously, the most robust and
ideal mechanisms for protein immobilization involve covalent linkages. However, this
technique is often confounded by the potential for multiple reaction sites on a given
protein, which could render proteins that are oriented incorrectly for their function. UAA
mutagenesis allows for the development of a bioorthogonal handle in a predetermined
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site.(34) Based on previous UAA immobilization results, an epoxy-activated sepharose
resin was derivatized with propargyl alcohol in the presence of trimethylamine (TEA) by
stirring overnight at room temperature.(28) This afforded a resin with an alkyne
functionality that could be employed as a reaction partner with the azido-GFP series (see
Figure 2).
H 2N

SO2H
O

SO2H
NH

CO2H

O

NH

Alexafluor 488

Figure 11. Verification of alkyne functiaonlized resin. Prepared alkyne sepharose resin was reacted with an alkyne
containing fluorophore (Alexafluore 488) in the presence and absence of Glaser-Hay conjugating conditions (50 mM
CuI and 50 mM TMEDA), which has been shown to conjugate two terminal alkynes. Following successive rinsing with
PBS, fluorescence was only observed in the presence of catalyst, demonstrating that the fluorophore was bound to the
resin via generation of a diyne linkage and not through non-specific interaction. This reaction verifies that the
sepharose resin was indeed derivatized with a terminal alkyne handle for immobilization experiments.

It was expected that by extending the tethering distance of the functional handle of the
UAA, and thus the site of bioorothogonal reactivity, the steric hindrance due to the
protein’s bulk could be decreased and immobilization efficiency could be improved. As
such, the p2AzY-, p3AzY -, and p4AzY -mutated GFPs were exposed to copper click
conditions (50 mM CuSO4, 50 mM TCEP, and 5 mM TBTA) at fixed concentration of
GFP (roughly 0.250 mg/mL). As a positive control, the pAzF-GFP, which has no tether
between the aromatic ring and the azide functional group, was also subjected to the same
copper click conditions. We have previously immobilized the p-azidophenylalanine
mutated GFP on the alkyne-functionalized sepharose resin using similar conditions.(28)
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As a negative control, wild-type GFP, in which there is no azido-functional group present,
was also subjected to the same copper click conditions. This control provided a means to
rule out non-specific interactions as the reason for immobilization rather than the
selective copper click reaction. Results indicated that the copper click-based
immobilization strategy was effective for all of the mutants in the series (Figure 3).
Interestingly, the tether distance did factor into the efficiency of the immobilization
reaction but not as expected, as increased distance from the protein did not necessarily
lead to improved immobilization as measured by relative fluorescence intensity on a
microplate reader (Figure 3). However, confirming the results observed when coupling to
the Alexafluor488 dye, the p3AzY (n = 2) derivative again had the highest coupling and
immobilization efficiency, indicating that the interplay of structural rigidity and distance
is important when optimizing the bioconjugation reaction. This 3-carbon tether seems to
exploit the best properties of each factor, conferring a high coupling and immobilization
efficiency. The p4AzY (n = 3) had decreased immobilization efficiency. We hypothesize
that the increased flexibility afforded to this variant may decrease the propensity of its
azido handle to orient in the proper geometry in space for reaction.
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3

Figure 12. Click immobilization of GFP-151 mutants on a sepahrose resin with either an azide tethered
tyrosine UAAs or a p-azidophenylalanine. A) The immobilization of GFP at a fixed concentration of
0.246mg/mL of each mutant protein. Fluorscence signal at 528nm on a plate reader indicates that the n=2
GFP-151 azide tethered variant performed best for immobilization (immobilizations conducted in triplicate,
average standard deviation +/- 296). B) Image of the immobilized resins as irradiated at 365 nm on a
transilluminator. Overall, the tethered variants appeared to have a greater immobilization efficiency than
the traditional pAzF.

Based on these results, we next investigated the role of the methylene tether on alternate
reactions. Recently, we reported the first Glaser-Hay bioconjugation, linking two terminal
alkyne functionalities to yield a conjugated diyne. (18) Consequently, this reaction was
selected to explore the reactivity of the alkyne-GFP series. The alkyne-containing GFPs
were first conjugated to the same Alexafluor 488 alkyne dye previously employed in the
click reactions. All mutant proteins were subjected to conjugation conditions in the
presence of CuI (50 mM) and TMEDA (50 mM) and a control in the presence of the
alkyne fluorophore but in the absence of catalyst system. After 4 hours at 4 oC , the
proteins were denatured at 98 oC for 15 mins and then analyzed via SDS-PAGE (Figure
4A). These couplings were all successful, as demonstrated by a fluorescent band at ~26
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kDa; however, the different tethered derivatives reacted with different efficiencies.
Furthermore, no coupling was observed in the absence of the Glaser-Hay catalyst system,
even in the presence of the fluorophore, indicating that the bioorthogonal Glaser-Hay
chemistry is responsible for the conjugation between the fluorophore and the dye.
A

B

pPrF

C
n

-

1

2

3

pPrF

Figure 13. Glaser-Hay reactions of alkyne-containing GFP mutants. A) Bioconjugation of mutant GFPs with
AlexaFluor488 under Glaser-Hay conditions. TheCcoomassie stained gel (top) indicates the incorporation of all
tethered mutants into GFP-151. Moreover, the successful Glaser-Hay coupling with the fluorophore was confirmed via
fluorescent imaging of the same gel (bottom), as AlexaFluor fluorescence is only observed in reactions containing the
fluorophore and the CuI/TMEDA system (immobilizations conducted in triplicate, average standard deviation +/- 774).
B) Immobilization of alkyne-GFP mutants on a sepharose resin under Glaser-Hay conditions. Measuring resin
fluorescence on a plate-reader (Ex 395/Em 512), all GFPs were able to be immobilized. C) Immobilization was also
confirmed by GFP fluorescent imaging on a transilluminator.
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The alkyne series was also reacted with the alkyne-derivatized sepharose resin to assess
coupling efficiencies. All of the alkynyl-UAA containing GFP mutants could be
immobilized, as indicated by the presence of fluorescence on the resin after reaction with
CuI/TMEDA (Figure 4B and C). However, it appears that there is no relative benefit to
increasing the tether length, in contrast to the trends observed with the azide tethers.
Interestingly, the p-propargylphenylalanine, which has an alkynyl moiety closest to the
phenyl ring of phenylalanine, performed the best. Based on the proposed mechanism for
the Glaser-Hay reaction, we hypothesize the enhanced rigidity of the pPrF helps properly
orient the protein-resin interactons as the copper binds in an η1 fashion. Moreover, the
enhanced flexibility afforded by the novel alkynyl-UAAs may diminish their propensity
to react, as the steric bulk of the protein may be more predisposed to interact with the
resin. An odd/even effect is observed as the p3yneY-containing GFP performed the best
amongst the UAA-mutated GFPs in the immobilization experiment (Figure 4C). This
suggests that there may be some benefit, although slight, to increasing the distance of the
protein from the site of reactivity. This increase drops once the alkyl chain gets too
flexible, as evidenced by the drop in the p4yneY-containing GFP.
Interestingly, within the series, the conjugation partner also plays a role in efficiency as
the Glaser-Hay reaction with the small fluorophore was most efficient with the longer
tether (Figure 4A), whereas, reaction with the bulky resin required decreased flexibility.
Finally, conjugation with the bromo-GFP series was investigated utilizing a SN2 reaction.
The incorporation of this series with a different synthetase, followed by reaction with
thiols has previously been reported in a mammalian system;(32, 33) however, we were
interested to see if these synthetic intermediates could also be incorporated with the

39

pCNF aaRS. Due to the presence of many nucleophilic functional groups within
biological settings, this reaction is not truly bioorthogonal as cross-reactivity is likely.
Nevertheless, we reasoned that successful nucleophilic substitution with an amine resin,
immobilizing the GFP, was an ideal means to demonstrate the successful incorporation of
the bromo-UAAs and the generation of the p2BrY-, p3BrY-, p4BrY-GFPs. An aminofunctionalized sepharose resin was generated using etheylenediamine (see Experimental).
This resin was then subjected to the bromo-GFP series in the presence of a carbonate
buffer (pH = 9.5). As a control, wild-type GFP was subjected to the same conditions.
Gratifyingly, all of the bromo-containing GFPs successfully immobilized, with p4BrY
performing the best (Figure 5 and 6). Compared to the other functionalities and reactions,
in which the three carbon alkyl chain variant of the UAA consistently performed the best,
this was the only case where we found a four-carbon alkyl chain to increase the
propensity to immobilize. This is to be expected, as this bromo-tethered variant is the
least sterically hindered by the protein’s bulk and will therefore perform the best in a
nucleophilic substitution reaction. Furthermore, the wild-type GFP was not immobilized,
as indicated by minimal fluorescence on a microplate reader, verifying that the presence
of the bromine-functionality was responsible for the immobilization, and thereby
demonstrating that we had successfully synthesized and incorporated bromo-tyrosine
UAAs.

Figure 14. Immobilization of bromide-containing UAAs on a derivatized sepharose resin. A) Fluoresence was
determined on a platereader (Ex 395/Em 512), with the increased tether increasing immobilization efficiency
(immobilizations conducted in triplicate, average standard deviation +/- 1401). B) Image of bromo-UAAs immobilized
on the resin.

B
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Conclusion
In conclusion, nine, novel UAAs with various functional handles and alkyl chains
were synthesized. Furthermore, all UAAs were successfully incorporated into GFP using
a single promiscuous aaRS. The novel functional handles present in the UAAs allowed
access to a range of different bioorthogonal chemistries. Additionally, the presence of
alkyl chains of different lengths seemed to successfully distance the site of reaction from
the protein surface, having differential effects on the outcome of the different
bioorthogonal reactions. In particular, we have elaborated upon a previously reported
immobilization technique using an azido-containing GFP. We improved the
immobilization efficiency by increasing the distance between the protein and the site of
the CuAAC reaction. In addition, we have also demonstrated the utility of the Glaser-Hay
reaction for protein immobilization.
Based on these results, we have illustrated the potential of UAA-mutagenesis to
generate unique, site-specific functional handles in proteins for the preparation of various
bioconjugates. This technology has downstream molecular imaging applications for the
study of protein dynamics in vivo, as well as applications involving immobilized enzymes
and the synthesis of well-defined therapeutic agents.

Experimental
General Solvents and reagents, including the AlexaFluor 488 Alkyne, were obtained
from Sigma Aldrich or Acros Organics and used without further purification. The BocOMe-Tyr was purchased from Matrix Scientific and the 5-Bromo-1-pentyne was
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procured from Enamine. Epoxy-activated Sepharose 6B was obtained from GE
Healthcare. Plasmids were provided by the laboratory of Dr. Peter Schultz at The Scripps
Research Institute. Reactions were conducted under ambient atmosphere with solvents
directly from the manufacturer without further purification. All proteins were purified
according to manufacturer’s protocols using a Qiagen Ni-NTA Quik Spin Kit. Compound
purities were assessed by NMR and found to be 90% or greater for all compounds.
Fluorescence measurements were acquired on a Synergy HT microplate reader, with a
485 nm excitation filter and a 528 nm emission filter. All NMRs were acquired on an
Agilent Technologies 400 MHz NMR. Compound purities were assessed by NMR and
found to be 90% or greater for all compounds. MS analysis was conducted on a Thermo
Finnigan LCQ Deca Quadropole Ion Trap via direct injection of samples at 100 µM in a
1:1 H2O/MeOH solution.
Synthesis of p-Bromo-ethyl-Boc-OMe-Tyrosine (1) A solution of Boc-Tyrosine-OMe
(0.500 g, 1 eq, 1.693mmol) in acetone (5 mL) was prepared in a flame-dried vial. To this
solution, potassium carbonate (0.70 g, 3 eq, 5.08 mmol) was added, followed by the
addition of dibromoethane (292 µL, 2 eq, 3.38 mmol). The reaction stirred overnight at
55 °C, then cooled to room temperature, and filtered into a round-bottom flask. The
solvent was removed from the filtrate by rotatory evaporation. The solid was then
purified by silica gel chromatography (gradient of 9:1 hexanes/ethyl acetate to 7:1
hexanes/ethyl acetate to 5:1 hexanes/ethyl acetate) and afforded the desired product as a
1
clear oil (36 mg, 0.089 mmol, 5.3% yield). H NMR (400 MHz, CDCl3): δ 7.02 (d, J =8
Hz, 2H), 6.82 (d, J = 8 Hz, 2H), 4.96 (d, J = 8 Hz, 1H), 4.53 (d, J= 8 Hz, 1H), 4.01 (t, J =
4 Hz, 2 H), 3.70 (s, 3 H), 3.51 (t, J = 8 Hz, 2 H), 2.94 (m, 2 H), 1.41 (s, 9 H)

42

Synthesis of p-Bromo-propyl-Boc-OMe-Tyrosine (2) A solution of Boc-Tyrosine-OMe
(0.50 g, 1 eq, 1.69 mmol) in acetone (5 mL) was prepared in a flame-dried vial. To this
solution, potassium carbonate (0.70 g, 3 eq, 5.08 mmol) was added, followed by the
addition of 1,3- dibromopropane (345 µL, 2 eq, 3.38 mmol). The reaction stirred
overnight at 55 °C, then cooled to room temperature, and filtered into a round-bottom
flask. The solvent was removed from the filtrate by rotatory evaporation. The solid was
then purified by silica gel chromatography (gradient of 9:1 hexanes/ethyl acetate to 7:1
hexanes/ethyl acetate to 5:1 hexanes/ethyl acetate) and afforded the desired product as a
1
clear oil (18 mg, 0.283 mmol, 33.5% yield). H NMR (400 MHz, CD3OD): δ 6.99 (d, J =
8 Hz, 2 H), 6.78 (d, J = 8 Hz, 2 H), 5.07 (d, J = 4 Hz, 1 H), 4.59 (d, J = 4 Hz, 1 H), 4.01
(t, J =4 Hz, 2 H), 3.65 (s, 3 H), 3.53 (t, J =4 Hz, 2 H), 2.97 (m, 2 H), 2.24 (quintet, J = 4
Hz, 2 H), 1.37 (s, 9 H)
Synthesis of p-Bromo-butyl-Boc-OMe-Tyrosine (3) A solution of Boc-Tyrosine-OMe
(0.50 g, 1 eq, 1.69 mmol) in acetone (5 mL) was prepared in a flame-dried vial. To this
solution, potassium carbonate (0.70 g, 3 eq, 5.08 mmol) was added, followed by the
addition of 1,4- dibromobutane (369 µL, 2 eq, 3.38 mmol). The reaction stirred overnight
at 55 °C, then cooled to room temperature, and filtered into a round-bottom flask. The
solvent was removed from the filtrate by rotatory evaporation. The solid was then
purified by silica gel chromatography (gradient of 9:1 hexanes/ethyl acetate to 7:1
hexanes/ethyl acetate to 5:1 hexanes/ethyl acetate) and afforded the desired product as a
1
white crystal (342mg, 0.795 mmol, 46.9% yield). H NMR (400 MHz, CDCl3): δ 7.01
(d, J = 8 Hz, 2 H), 6.79 (d, J = 8 Hz, 2 H), 4.97 (d, J = 8 Hz, 1 H), 4.52 (d, J = 8 Hz, 1 H),
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3.95 (t, J = 4 Hz, 2 H), 3.69 (s, 3 H), 3.47 (t, J = 4 Hz, 2 H), 3.01 (m, 2 H), 2.04 (m, 2 H),
1.92 (m, 2 H), 1.40 (s, 9 H)
Synthesis of p-Azido-propyl-Boc-OMe-Tyrosine (5) Dry dimethylformamide (DMF, 5
mL) was added to a vial containing 2 (60 mg, 1 eq, 0.137 mmol). This solution was then
transferred to a flame dried vial, and sodium azide (11 mg, 1.2 eq, 165 mmol) was added.
The reaction stirred overnight at 65°C. The organic layer was quenched with brine and
then extracted with methylene chloride (DCM, 10 mL x 3). The organic layer was back
extracted with brine (10 mL). Theorganic layer was then dried with magnesium sulfate,
filtered, and rotovapped. Column chromatography (silica gel, 1:1 hexanes ethyl acetate)
1
afforded the desired product as a crystal (32 mg, 0.085 mmol, 61.7% yield). H NMR
(400 MHz, CDCl3): δ 7.03 (d, J = 12 Hz, 2 H), 6.82 (d, J = 12 Hz, 2 H), 4.96 (d, J = 8
Hz, 1 H), 4.53 (d, J = 8 Hz, 1 H), 4.01 (t, J = 4 Hz, 2 H), 3.71 (s, 3 H), 3.46 (t, J = 8 Hz, 2
H), 3.02 (m, 2H), 2.03 (quintet, J = 4 Hz, 2 H), 1.41 (s, 9 H).

13

C (400 MHz, CDCl3): δ

172.4, 157.7, 155.1, 130.3, 128.2, 114.5, 79.9, 64.4, 54.5, 52.2, 48.2, 37.4, 28.8, 28.3.
Synthesis of p-Azido-butyl-Boc-OMe-Tyrosine (6) Tyrosine derivative 3 (252 mg, 1 eq,
0.59 mmol) was dissolved in a solution of DMF (12 mL) in a flame-dried vial. Sodium
azide (76 mg, 2 eq, 1.17 mmol) was then added to the solution. The reaction was stirred
overnight at 65 °C, then quenched brine and extracted with methylene chloride (DCM, 10
mL x 3). The organic layer was then back extracted with brine (10 mL). The organic
layer was dried with magnesium sulfate, filtered, and rotovapped. Column
chromatography (silica gel, 3:1 hexanes ethyl acetate) afforded the desired product (132
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1
mg, 0.349 mmol, 57% yield). H NMR (400 MHz, CDCl3): δ 7.03 (d, J = 8 Hz, 2 H),
6.84 (d, J = 8 Hz, 2 H), 4.97 (d, J = 8 Hz, 1 H), 4.54 (d, J = 8 Hz, 1 H), 3.95 (t, J = 8 Hz,
2 H), 3.72 (s, 3 H), 3.36 (t, J = 8 Hz, 2 H), 3.05 (m, 2 H), 1.80 (m, 4 H), 1.43 (s, 9 H).
13

C (400 MHz, CDCl3): δ 172.4, 157.9, 130.3, 114.5, 67.1, 54.5, 52.2, 51.1, 37.4, 28.3,

26.5, 25.7.
Synthesis of p-Alkynyl-ethyl-Boc-OMe-Tyrosine (7) To a flame dried vial, DMF (5 mL)
and Boc-Tyrosine-OMe (295 mg, 1 eq, 1.00 mmol) was added without stirring followed
by the slow addition of potassium tert-butoxide (337 mg, 3 eq, 3.00 mmol). The reaction
immediately turned dark green. This mixture was allowed to stir at 100 °C for 10 mins,
then 4-bromo-1-butyne was added (94 µL, 133 mg, 1 eq, 1.00 mmol). The mixture
immediately turned a lighter, more brownish green. The mixture was then capped and
allowed to stir at 80 °C overnight. Following reaction, brine (10 mL) was added followed
by the addition of ether (10 mL). The aqueous layer was then drained and the ether layer
was washed with brine (10 mL x 3). The ether layer was collected and then the aqueous
layer was back extracted with additional ether. The combined ether layers were then dried
and rotovapped. Column chromatography (silica gel, 5:1 hexanes/ethyl acetate) yielded
1
the desired product as an oil (23 mg, 0.066 mmol, 3.9% yield). H NMR (400 MHz,
CDCl3): δ 6.99 (d, J = 8 Hz, 2 H), 6.75 (m, 2 H), 4.47 (m, 1 H), 4.45 (m, 1 H), 4.07 (t, J =
4 Hz, 2 H), 3.70 (s, 3 H), 3.54 (m, 2 H), 3.31 (m, 2 H), 2.66 (td, J = 8 Hz, J = 4 Hz, 2 H),
2.05 (s, 1 H), 1.43 (s, 9 H).

13

C (400 MHz, CDCl3): δ 171.2, 155.0, 131.3, 130.2, 115.5,

115.3, 81.7, 58.84, 28.5, 27.7, 26.1, 25.5, 19.5.
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Synthesis of p-Alkynyl-propyl-Boc-OMe-Tyrosine (8) Boc-Tyrosine-OMe (114 mg, 2
eq, 0.385 mmol) was added to a flame-dried vial. Cesium carbonate (254 mg, 3 eq, 0.578
mmol) was then added, followed by dry DMF (3 mL). This mixture was stirred at 100 °C
for 20 mins. 5- Bromo-1-pentyne (20 µL, 1 eq, 0.193 mmol) was then added to the
mixture, as well as a catalytic potassium iodide. The reaction was stirred overnight at 100
°C, then cooled to room temperature and washed with brine (10 mL) and ether (10 mL).
The ether layer was then washed with brine (10 mL x 3). The brine layer was then backextracted with ether (10 mL). The organic layers were combined, dried with magnesium
sulfate, filtered, and rotovapped. Column chromotagrophay (silica gel, 5:1 hexanes/ethyl
acetate) to yield the desired product as a white crystal (22 mg, 0.061 mmol, 31.6% yield).
1

H NMR (400 MHz, CDCl3): δ 7.02 (d, J = 12 Hz, 2 H), 6.82 (d, J = 12 Hz, 2 H), 4.95

(d, J = 8 Hz, 1 H), 4.53 (d, J = 8 Hz, 1 H), 4.03 (t, J = 4 Hz, 2 H), 3.71 (s, 3 H), 3.02 (m, J
= 8 Hz, 1 H), 2.39 (t, J = 4 Hz, 2 H), 1.97 (m, J = 8 Hz, 2 H), 1.55 (s, 1 H), 1.41 (s, 9 H).
13

C (400 MHz, CDCl3): δ 172.4, 157.9, 130.3, 127.9, 114.5, 83.5, 79.9, 68.8, 66.0, 54.5,

52.2, 37.4, 28.3, 28.2, 21.1, 15.1.
Synthesis of p-Alkynyl-butyl-Boc-OMe-Tyrosine (9) Ether (10 mL) was added to a
flame- dried round bottom flask followed by pyridine (18 µL, 16.2 mg, 0.21 mmol) and
o
6-hexyne-1-ol (342 µL, 300 mg, 3 eq, 3.06 mmol) then heated to 40 C. Phosphorous
(III) bromide (97 µL, 276 mg, 1 eq, 1.02 mmol) was then slowly added through the reflux
condenser, producing a white gas and precipitate in the process. The reaction was then
refluxed for 2 hours, cooled in an ice bath and diluted with ether (25 mL). The organic
mixture was then washed twice with a solution of saturated sodium bicarbonate (20 mL x
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2) and a single wash with brine (20 mL). The organic layer was then dried and
rotovapped, to yield a clear, pungent oil that was the 6-Bromo-hexyne product (295 mg).
A solution of Boc-Tyrosine-OMe (1.089g, 2 eq, 3.69 mmol) in acetone (1 mL) was then
prepared in a flame-dried vial. The 6-Bromohexyne product (295 mg, 1 eq, 1.84 mmol)
was then dissolved in 4 mL of acetone, and transferred to the vial containing the tyrosine
solution. To this mixture, cesium carbonate was added (1.802g, 3 eq, 5.53 mmol). The
reaction was stirred overnight at 60 °C then cooled to room temperature and filtered. The
precipitate was washed with ethyl acetate and the collected filtrate was concentrated by
rotatory evaporation. Column chromatography (silica gel, gradient of 7:1 hexanes/ethyl
acetate to 5:1 hexanes/ethyl acetate to 1:1 hexanes/ethyl acetate) afforded the desired
1
product as a white crystal (62 mg, 0.165 mmol, 9.0% yield). H NMR (400 MHz,
CDCl3): δ 7.01 (d, J = 8 Hz, 2 H), 6.81 (d, J = 8 Hz, 2 H), 4.95 (d, J = 8 Hz, 1 H), 4.53
(d, J = 8 Hz, 1 H), 3.95 (t, J = 8 Hz, 2 H), 3.70 (s, 3 H), 3.02 (m, 2 H), 2.27 (td, J = 8 Hz,
4 Hz, 2 H), 1.96 (t, J = 4 Hz, 1 H), 1.90 (m, 2 H), 1.71 (m, 2 H), 1.41 (s, 9 H).

13

C (400

MHz, CDCl3): δ 172.4, 158.0, 130.7, 127.8, 114.5, 84.1, 68.6, 67.2, 52.2, 37.4, 28.3,
25.0, 18.1.
General Protocol for Removal of Methyl Protecting Group To deprotect the C-terminus
of the unnatural amino acids, 500 µL of dioxane and 500 µL of 1M lithium hydroxide
were added to a vial containing the unnatural amino acid on ice. The vial was then stirred
at room temperature for 2 hours. The dioxane was removed by rotatory evaporation and
6M hydrochloric acid was added to dropwise until a pH of 4 was obtained. The product
was then extracted with ethyl acetate into a vial, and the organic layer was dried with
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magnesium sulfate and filtered and rotovapped.
General Protocol for Removal of tert-Butyloxy Protecting Group To the methyl-free
unnatural amino acid, 1 mL of 2% trifluoroacetic acid (200 µL trifluoroacetic acid into 10
mL of DCM) was added on ice to deprotect the N-terminus of the unnatural amino acid.
The reaction was stirred at room temperature for 1 hour, and the DCM was then removed
by rotatory evaporation, affording the final deprotected unnatural amino acid, typically in
as a white crystalline solid.
Synthesis of p-Bromoethyltyrosine (p2BrY, 10) According to the general protocol
outlined above, 1 was deprotected to yield a white crystalline powder (26 mg, 0.090
1
mmol, ~100% yield). H NMR (400 MHz, CD3OD): δ 7.11 (d, J = 8 Hz, 2H), 6.82 (d, J
= 8 Hz, 2H), 4.23 (t, J = 4 Hz, 2 H)
1
Synthesis of p-Bromopropyltyrosine (p3BrY, 11) According to the general protocol
outlined above, 2 was deprotected to yield a white crystalline powder (21 mg, 0.069
1
mmol, 24.5% yield). H NMR (400 MHz, CD3OD): δ 7.10 (d, J = 8 Hz, 2 H), 6.81 (d, J
= 8 Hz, 2 H), 3.57 (t, J = 4 Hz, 2 H), 2.23 (quintet, J = 4 Hz, 2 H). Values corroborated
by literature (1) 1 Xiang, Z.; Lacey, V.; Ren, H.; Xu, J.; Burban, D.; Jennings, P.; Wang,
L., Proximity-Enabled Protein Crosslinking through Genetically Encoding Haloalkane
Unnatural Amino Acids. Angew Chem Int Ed 2014, 53, 2190-2193.
1
Synthesis of p-Bromobutyltyrosine (p4BrY, 12) According to the general protocol
outlined above, 3 was deprotected to yield a white crystalline powder (58 mg, 0.183
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1
mmol, 23.0% yield). H NMR (400 MHz, CD3OD): δ 7.09 (d, J = 8 Hz, 2 H), 6.79 (d, J
= 8 Hz, 2 H), 3.94 (t, J = 4 Hz, 2 H), 2.80 (t, J = 8 Hz, 1 H), 1.98 (m, 2 H), 1.86 (m, 2 H).
Values corroborated by (1)
1
Synthesis of p-Azidopropyltyrosine (p3AzY, 14) According to the general protocol
outlined above, 5 was deprotected to yield a white crystalline powder (21 mg, 0.08 mmol,
1
94.1% yield). H NMR (400 MHz, CD3OD): δ 7.10 (d, J = 8 Hz, 2 H), 6.81 (d, J = 8 Hz,
2 H), 4.90 (s, 1 H), 4.16 (t, J = 4 Hz, 2 H), 1.97 (m, J = 4 Hz, 2 H).

13

C (400 MHz,

CD3OD): δ 172.5, 156.1, 128.37, 127.7, 112.5, 110.0, 62.8, 26.9, 25.7; MS: calcd for
C12H17N4O3: 265.293, found 265.290. Values corroborated by (1).
Synthesis of p-Azidobutyltyrosine (p4AzY, 15) According to the general protocol
outlined above, 6 was deprotected to yield a white crystalline powder (28 mg, 0.100
1
mmol, 30.0% yield). H NMR (400 MHz, CD3OD): δ 7.09 (d, J = 12 Hz, 2 H), 6.79 (d, J
= 12 Hz, 2 H), 3.93 (t, J = 4 Hz, 2 H), 1.99 (m, 2 H), 1.87 (m, 2 H).

13

C (400 MHz,

CD3OD): δ 172.4, 156.3, 154.8, 128.3, 127.5, 112.4, 77.5, 65.0, 31.1, 27.8, 26.1, 25.7;
MS: calcd for C13H19N4O3: 279.145, found 279.142
Synthesis of p-Alkynylethyltyrosine (p2yneY, 16) According to the general protocol
outlined above, 7 was deprotected to yield a white crystalline powder (15 mg, 0.064
1
mmol, 97% yield). H NMR (400 MHz, CD3OD): δ 7.00 (d, J = 4 Hz, 2 H), 6.67 (d, J =
4 Hz, 2 H), 4.25 (m, 2 H), 2.59 (td, J = 4 Hz, J = 8 Hz, 2 H), 2.27 (t, J = 4 Hz, 2 H).
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13
C

(400 MHz, CD3OD): δ 172.5, 170.0, 128.2, 126.2, 113.1, 77.5, 58.5, 52.0, 49.9, 43.7,
41.7, 25.7, 17.8, 11.4; MS: calcd for C13H16NO3: 234.113, found 234.113
Synthesis of p-Alkynylpropyltyrosine (p3yneY, 17) According to the general protocol
outlined above, 8 was deprotected to yield a white crystalline powder (13 mg, 0.053
1
mmol, 86.2% yield). H NMR (400 MHz, CD3OD): δ 7.53 (d, J = 12 Hz, 2 H), 7.24 (d, J
= 12 Hz, 2 H), 4.44 (t, J = 4 Hz, 2 H), 2.76 (td, J = 8 Hz, 4 Hz, 2 H), 2.63 (t, J = 4 Hz, 1
H), 2.34 (m, 2 H).

13

C (400 MHz, CD3OD): δ 172.4, 128.3, 112.4, 66.9, 64.5, 26.5, 25.7,

12.7; MS: calcd for C14H18NO3: 248.128, found 248.129
Synthesis of p-Alkynylbutyltyrosine (p4yneY, 18) According to the general protocol
outlined above, 9 was deprotected to yield a white crystalline powder (15 mg, 0.057
1
mmol, 34.5% yield). H NMR (400 MHz, CD3OD): δ 7.09 (d, J = 8 Hz, 2 H), 6.79 (d, J
= 8 Hz, 2 H), 3.93 (t, J = 4 Hz, 2 H), 2.21 (td, J = 8 Hz, 4 Hz, 2 H), 2.18 (t, J = 4 Hz, 2
H), 1.83 (m, 2 H), 1.64 (m, 2 H).

13

C (400 MHz, CD3OD): δ 172.4, 156.3, 128.2, 127.4,

112.4, 81.7, 77.5, 66.7, 65.4, 26.3, 25.7, 23.3, 15.8; MS: calcd for C15H20NO3: 262.144,
found 262.142
General GFP Expression A pET-GFP-TAG plasmid (0.5 µL) was co-transformed with a
pEVOL-pCNF plasmid (0.5 µL) into Escherichia coli BL21(DE3) cells using an
Eppendorf eporator. The cells were then plated and grown on LB agar in the presence of
chloramphenicol (34 mg/mL) and ampicillin (50 mg/mL) at 37 ̊ C overnight. One colony
was then used to inoculate LB media (4 mL) containing both ampicillin and

50

chloramphenicol. The culture was incubated at 37 ̊ C overnight and used to inoculate an
expression culture (10 mL LB media, 50 mg/mL Amp, 34 mg/mL Chlr) at an OD600 0.1.
The cultures were incubated at 37 ̊ C to an OD600 between 0.6 and 0.8, and protein
expression was induced by addition of UAA (100 µL, 100 mM) and 20 % arabinose (10
µL) and 0.8 mM isopropyl β-D-1-thiogalactopyranoside (IPTG; 10 µL). The cultures
were incubated at 30 ̊ C for 16-20 h then centrifuged at 5,000 rpm for 10 minutes and
stored at -80 ̊ C for 3 hours. The cell pellet was resuspended using 500 µL of Bugbuster
(Novagen) containing lysozyme, and incubated at 37 ̊ C for 20 minutes. The solution was
transferred to an Eppendorf tube and centrifuged at 15,000 rpm for 10 minutes, then the
supernatant was added to an equilibrated His- pur Ni-NTA spin (Qiagen) column and
GFP was purified according to manufacturer’s protocol. Purified GFP was analyzed by
SDS-PAGE (BioRad 10% precast gels, 150V, 1.5h), and employed without further
purification. Protein concentrations were determined both by a BCA assay and
fluorescence measurements.
Biological Cu(I)-1,3-dipolar Cycloaddition Reaction Clicks on azido-tyrosine GFPmutants were performed in 1.5mL Eppendorf tubes. To the experimental tube, in order,
the following were added: 2 µL of 50mM CuSO4, 20 µL of 5mM Tris[(1-benzyl-1H1,2,3-triazol-4- yl)methyl]amine (TBTA), 5 µL of azido-tyrosine mutated GFP (with
either an ethyl, propyl, or butyl tether) in PBS, 10 µL of 488-Alexafluorophore-alkyne,
50 mM of tris(2- carboxyethyl)phosphine (TCEP), and 11 µL of phosphate buffer
solution (PBS; 10 mM Na2HPO4, 2 mM KH2PO4, 2.7 mM KCl, 137 mM NaCl, pH =
7.4) to bring the reaction to a 50 µL volume. Control reactions were performed with 20
µL azido-tyrosine mutated GFP samples (either ethyl, propyl, or butyl) and 10 µL 1 mM
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488-Alexafluorophore in the absence of the Cu- 1,3-dipolar cycloaddition catalysts
(CuSO4, TBTA, and TCEP) to ensure that successful reactions were not the result of
non-specific interactions between the protein and fluorophore. The control reaction was
brought to 50 µL volume using PBS. All mixtures were reacted for 10 hours at 4°C. The
reactions were then transferred to concentrator column (10k MWCO, Corning Spin-X)
pre-wet with PBS and spun at maximum speed in a tabletop centrifuge for 2 minutes.
They were then washed with 100 µL portions of PBS and spun for another 2 minutes.
This process was repeated for a total of seven washes, and the final spin time was
adjusted to bring the samples to a concentration of ~25 µL.
Biological Glaser-Hay Coupling Glaser-Hay couplings on alkyne-tyrosine mutated GFP
were performed in 1.5mL Eppendorf tubes. To the experimental tube, the following was
added in order: 3 µL of 50mM CuI, 3 µL 50 mM trimethylethylenediamine (TMEDA),
10 µL of 1 mM 488-Alexafluorophore alkyne, 20 µL of alkyne-tyrosine mutated GFP
(with either ethyl, propyl, or butyl tether) in PBS for a total reaction volume of 36 µL.
Control reactions were performed with 6 µL PBS, 10 µL 488-Alexafluorophore alkyne,
and 20 µL of alkyne-tyrosine mutated GFP (with either ethyl, propyl, or butyl tether) to
ensure that successful reactions were not the result of non-specific interactions between
the protein and fluorophore. All mixtures were reacted for 4 hours at 4°C. The reactions
were then transferred to concentrator column (10k MWCO, Corning Spin-X) pre wet
with PBS and spun at maximum speed in a tabletop centrifuge for 2 minutes. They were
then washed with 100 µL portions of PBS and spun for another 2 minutes. This process
was repeated for a total of seven washes, and the final spin time was adjusted to bring the
samples to a concentration of ~25 µL (as indicated by the marking on the column).
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Immobilization of Alkynyl- or Amino- Functionality onto Epoxy Sepharose 6B Resin
Epoxy-activated 6B Sepharose (GE Healthcare, 200 mg) was added to a filter syringe and
washed with distilled water (5 washes, 3 mL). Alkyn-ol (700 µmol) or ethylenediamine
(700 µmol) and coupling buffer (3.5 mL, 1x PBS brought to pH 13.0 w/ NaOH) was
added to a vial followed by the washed resin. The mixture was shaken at room
temperature for 16 h. The resin was transferred to a filter syringe and washed with
coupling buffer (4 mL). The sepharose was transferred to a vial and capped with
ethanolamine (3.5 mL). The resin was incubated at 30 ̊C for four hours then washed in a
filter syringe with 0.1 M acetate buffer (10 mM) and 0.1 M Tris- HCl buffer (pH 4 and
pH 8 respectively, 3 alternating washes with 3 mL each).
To verify that we had successfully immobilized ethelyenediamine on the sepharose resin,
amino-, alkynyl-, and unreacted sepharose resin were placed in carbonate buffer (0.2 M
Na2CO3, 0.2M NaHCO3, pH = 9.) in the presence of 5 µL of FITC. After washing,
imaging with a transilluminator demonstrated the successful derivitization of the
sepharose resin with ethylenediamine as little fluorescence is observed on the alkynyl
resin and practically no fluorescence was observed on the unreacted sepharose (see
Figure 7).

Figure 15. Validation that the sepharose resin was derivatized with an amine functional group using the FITC dye,
which contains an isothiocyanate group susceptible to nucleophilic attack by an amine. Because the coupling buffer is
generated using a hydroxide ion, we wanted to verify the propensity of reacted coupling buffer on the resin to react
with the FITC dye (alkynyl-). As can be seen, the amino-resin is much more fluorescent than the alkynyl resin, due to
the presence of the nucleophilic amine group. This verifies that we did indeed generate an amine resin for our
immobilization studies.
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Protocol for Immobilization of Azido-Tyrosine Mutated GFP Series All azido-tyrosine
GFP mutants were brought to a final concentration of 0.250 mg/mL using PBS. To a 1.5
mL Eppendorf tube, 15 µL of each azido-tyrosine GFP mutant was added (with either an
ethyl, propyl, or butyl tether). To this, the Cu(I)-1,3-dipolar cycloaddition reaction
conditions were then added. In the following order, 5 µL of 4 mM TCEP, 6 µL 1 mM
CuSO4, 15 µL PBS, and 20 µL 5 mM TBTA were then added to the mix. This liquid
mixture was then mixed and transferred to a 1.5 mL Eppendorf that contained 15 mg preweighed alkyne-derivatized sepharose resin. A positive control consisting of the
conditions above using p-azidophenylalanine-GFP, which was previously demonstrated
to immobilize on the alkyne-derivatized sepharose resin, was also prepared. All samples
were allowed to react overnight at 4 °C, then transferred to spin columns by adding PBS
(200 µL x 2) to the reaction in order to aid the transfer. The reaction was then purified at
1.1 rcf on a table-top microcentrifuge for 1 minute, and washed two times with 100 µL
portions at 1.1 rcf for 1 minute each. The protein-immobilized sepharose resin was then
transferred to a clear Eppendorf tube for visualization and fluorescence quantification on
a microplate reader.
Protocol for Immobilization of Alkynyl-Tyrosine Mutated GFP Series All alkynyltyrosine GFP mutants were brought to a final concentration of 0.400 mg/mL using PBS.
To a 1.5 mL Eppendorf tube, 5 µL of 50 mM CuI, 5 µL of 50 mM TMEDA and 10 µL of
PBS were added. Followed by 20 µL of the alkynyl-GFP. This liquid mixture was then
mixed and transferred to a 1.5 mL Eppendorf tube that contained 20 mg pre-weighed
alkyne-derivatized sepharose resin. A positive control consisting of the conditions above
using p-propargylphenylalanine-GFP, which was previously demonstrated to immobilize
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on the alkyne-derivatized sepharose resin, was prepared. All samples were allowed to
react at 4 °C for 4 hrs, then transferred to spin columns by adding PBS (200 µL x 2) to
the reaction in order to aid the transfer. The reaction was then purified at 1.1 rcf on a
table-top microcentrifuge for 1 minute, and washed two times with 100 µL portions at 1.1
rcf for 1 minute each. The protein-immobilized sepharose resin was then transferred to a
clear Eppendorf tube for visualization and fluorescence quantification on a microplate
reader.
Protocol for Immobilization of the Bromo-Tyrosine Mutated GFP Series To a 1.5 ml
Eppendorf tube, 15 mg of amino-functionalized sepharose resin was added. To the
sepharose resin, 10 µL of a carbonate buffer solution (pH = 9.5) and 40 µL of bromocontaining GFP in an imidazole elution buffer were added. A negative control consisting
of the conditions above using wild type GFP was also prepared. The reactions were
incubated overnight at 4 °C, then transferred to spin columns by adding PBS (200 µL x 2)
to the reaction in order to aid the transfer. The reaction was then purified at 1.1 rcf on a
table-top microcentrifuge for 1 minute, and washed two times with 100 µL portions at 1.1
rcf for 1 minute each. The protein- immobilized sepharose resin was then transferred to a
clear Eppendorf tube for visualization and fluorescence quantification on a microplate
reader.
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CHAPTER 3: EXPANDING THE SCOPE OF ALKYNE-MEDIATED
BIOCONJUGATIONS THROUGH A BIOLOGICAL CADIOT-CHODKIEWICZ
REACTION

The Glaser-Hay coupling of two terminal alkynes in the presence of CuI and
TMEDA affords a diyne.29, 30 The reaction brings together two terminal alkynes to
form a diyne linkage; however, is not redox neutral and has chemoselectivity
issues. These issues arise as there is not a means to differentiate the two terminal
alkynes, resulting in 3 possible products. Recently, we demonstrated a
bioorthogonal variant of the Glaser-Hay reaction that can be conducted in an
aqueous setting under physiological conditions.22 Using a terminal alkynecontaining UAA, we were able to demonstrate that the reaction proceeds to
completion within approximately 6 hrs at 4 oC. As previously mentioned, the
Glaser-Hay coupling of terminal alkynes has a chemoselectivity issue when the
terminal alkynes differ, resulting in the formation of unwanted homodimers.
However, due to the steric bulk of the protein, we found that the homodimerization
of the reaction was mostly inhibited, leading to primarily the desired protein
heterodimer product. As such we were able to demonstrate that the Glaser-Hay
reaction could be employed as a novel bioorthogonal chemistry, yielding stable
conjugates with well-defined geometries. However, the reaction was limited by the
oxidative damage of the protein, due to the mechanistic cycling of the copper
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through three different redox states. As a result, reactions proceeding for longer
than 6 hrs resulted in oxidative damage and protein degradation.
An alternative to the Glaser-Hay coupling is the Cadiot-Chodkiewicz reaction,
which affords a conjugated diyne via the reaction of a terminal alkyne and a haloalkyne (Figure 1). In the presence of a copper(I) salt and a monodentate
nitrogenous ligand, usually triethylamine (TEA), the reaction proceeds to form a
covalent linkage in the form of a conjugated diyne in a relatively chemoselective
fashion.23,

24

Furthermore, the overall reaction is net redox neutral, as a single

copper(I) catalyst goes through a series of oxidative additions and reductive
eliminations with the bromoalkyne and terminal alkyne reactant to yield the
conjugated diyne.25
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Figure 16. The Cadiot-Chodkiewicz reaction. A) Overall reaction scheme. B) Proposed reaction mechanism for the
reaction. Adapted from Organic Mechanisms: Reactions, Stereochemistry, and Synthesis by Reinhard Bruckner.

The Cadiot-Chodkiewicz reaction has diverse applications to many areas of
chemistry. It can be utilized in polymerization reactions, such as in the formation

61

of the backbone of a solid-state polymer crystal, or in the fabrication of
polymerized monolayer assemblies.26,

27

Additionally, several acetylenic natural

products exhibiting valuable biological properties can be obtained via a CadiotChodkiewicz reaction.28
A key component of the Glaser-Hay mechanism is the formation of a
copper(II)-hydroxyl intermediate, which has been shown to produce hydroxyl
radicals that are deleterious to living systems (Figure 2).33 Because the copper (I)
of the Cadiot-Chodkiewicz reaction is not thought to utilize copper(II)
intermediates, we reasoned that the chemistry could be employed in a biological
context to minimize previously observed oxidative damage. Furthermore, the
reaction is more chemoselective, as the use of a halo-alkyne minimizes the
formation of homodimer side products by differentiating the two alkynes.
Ultimately, this has the potential to increase the yield of the conjugated protein
product. Based on these facts and the limitations of the bioorthogonal Glaser-Hay,
we sought to develop a bioorthogonal variant of the Cadiot-Chodkiewicz reaction
that could be conducted in an aqueous setting and under physiological conditions.
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Figure 17. Proposed reaction intermediates in the Glaser-Hay coupling reaction. Adapted from (31).

Results and Discussion
In order to conduct and optimize a Cadiot-Chodkiewicz bioconjugation, new
UAAs harboring a terminal haloalkyne needed to be synthesized and incorporated
into a protein. In order to probe UAA-dependent effects on the reaction, aliphatic
and aromatic brominated alkynyl UAAs were prepared from the previously
reported

protected

p-propargyloxyphenylalanine

(pPrF,

1)

and

the

p-

ethynylphenylalanine (pEtF, 2) respectively.34, 35 Gratifyingly, the well-established
bromination of phenylacetylene using N-bromosuccinamide (NBS) and silver
nitrate worked well for the synthesis of both UAAs in moderate yields.36, 37
Scheme 8.
NBS
10% eq AgNO3
Acetone
RT
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Following deprotection,
the final UAAs, p-bromo-propargyloxyphenylalanine
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overall good yields (67% and 34% respectively) (Figure 1).
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p-

bromopropargyloxyphenylalanine (3, pBrPrF), p-bromoethynylphenylalanine (4, pBrEtF) incorporated into GFP-151 for
Glaser-Hay and Cadiot-Chodkiewicz reactions.

With the pBrPrF and pBrEtF in hand, it was imperative to incorporate these
UAAs into a model protein. Due to both its fluorescent properties and welldocumented prior use in UAA development technologies, green fluorescent protein
(GFP) was selected as a model system. Specifically, attempts were made to
incorporate newly synthesized UAAs at residue 151 by supressing the amber stop
codon. Furthermore, our previous work immobilizing GFP revealed that this
surface exposed site is ideal for UAA placement, as the rigidity of the residue
helps orient the bioorthogonal functional handle.38 In lieu of undergoing a tedious
aaRS selection process, we hoped to incorporate the brominated UAAs using the
previously described promiscuous pCNF aaRS.39,

40

The pCNF aaRS was

investigated first to incorporate pBrPrF and pBrEtF due to their structural
similarity to other UAAs that the pCNF aaRS incorporates.
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BL21(DE3) E. coli were co-transformed with a pEVOL-pCNF plasmid and a
pET-GFP-TAG151 plasmid and used to initiate an expression culture at OD600
=0.1 which was grown to an OD600 =0.7. The culture was subsequently centrifuged
and the cell pellet was resuspended in 4 mL of LB broth supplemented with
antibiotics, IPTG, arabinose, and the presence or absence of a UAA.34 This
previously reported expression protocol allowed for the minimization of the
amount of UAA employed, and was found to be very effective. After 18-20 h at 30
o

C, cells were pelleted and the expressed GFP was purified.
Gratifyingly, the promiscuous pCNF aaRS incorporated both brominated-UAA

variants with a higher fidelity than the simple terminal alkyne analogs (Figure 2).
As is to be expected, the smaller pBrEtF UAA, had a higher incorporation than the
pBrPrF. We hypothesize that the 1-bromo-alkyne moiety provides a degree of
hydrophobic character to the UAA, making the interaction between the amino acid
and the hydrophobic binding pocket of the aaRS more favourable.
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Figure 19. Expression of UAA-containing GFP151 using the promiscuous pCNF aaRS. A) A stained SDS-PAGE gel
indicated successful incorporation of 3 and 4 over background (-). A positive control, 1, was also utilized in an
expression. B) Data for overall incorporation of UAAs via the pCNF aaRS as measured via absorbance at 280 nm on a
nanodrop spectrophotometer (ε/1000 = 20, MW = 26.80 kDa). Data obtained were normalized to the pPrF UAA (1) to
demonstrate the difference in incorporation efficiency over the previously reported UAA.

With both brominated alkyne UAAs in hand, it was feasible to develop a
bioorthogonal Cadiot-Chodkiewicz reaction. Initial studies employed the pBrPrFcontaining GFP variant, to mimic previous Glaser-Hay pPrF-GFP studies and
provide an effective comparison. The Cadiot-Chodkiewicz reaction was carried out
in PBS (pH = 7) using copper iodide and triethylamine (TEA) (both at a final
concentration of 5 mM) in the presence of a terminal alkyne-containing
fluorophore (AlexaFluor 488 alkyne) at 4 oC for 6 hrs. The reaction was successful,
as fluorescence could be detected on a denatured SDS-PAGE gel only when
protein and fluorophore were exposed to the CuI/TEA system (Figure 5). Even
more exciting was the minimal protein degradation relative to the previously
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reported Glaser-Hay reaction. Also, due to the chemoselective nature of the
reaction no protein dimerization was detected, and fluorophore dimerization was
minimal and easily removed.
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Figure 20.. Bioorthogonal
Cadiot-Chodkiewicz reaction. The reaction performed on GFP (0.2 mg/mL) and AlexaFluor
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488 (0.2 mM) in the presence of 5 mM of CuI and 5 mM TEA at 4 C,. Fluorescence is only observed in the presence of
the CuI/TEA system.1"
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0.8" to further optimize the reaction, both copper concentrations and
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temperatures were varied. A 5 mM working Cu(I) concentration was found to be
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ideal, which represents a marked improvement over the ~50 mM concentrations
0.4"

required for the Glaser-Hay reaction (see Figure 6).
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Figure 21. Copper(I) salt optimization for the Cadiot-Chodkiewicz reaction. Data are normalized to the best performing
working concentration (50 mM).

Previous reports have indicated that in vivo use of copper-mediated bioorthogonal
chemistries required working concentrations of near 0.1 mM of copper(I) salt to
minimize cytotoxicity.10, 41 Thus, the minimized copper concentrations help bring bioorthogonal conjugated diyne chemistry into the range of in vivo use. These
copper concentrations also had no impact on GFP fluorescence as determined by
control reactions.
Additionally, the optimal temperature profile for the reaction was also
investigated. To do so, reactions were performed over a time course at both 37 ℃
and 4 ℃ by starting with the 24 hr reaction and ending with the 2 hour reaction
before running a denatured SDS-PAGE. We found that it was not necessary to
perform any washing steps, as the free fluorophore was run beyond the length of
the gel. This allowed us to visualize protein bound to fluorophore, and upon
staining with Coomassie blue, to image protein degradation relative to a zero time
point control.
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To analyze our data, we had to develop a meaningful interpretation that could
illustrate the interplay between conjugation efficiency and protein degradation. As
protein degradation increased, our Coomassie signal decreased, artificially
inflating the amount of conjugation observed (based on fluorescent signal alone).
To overcome this, fluorescent signals were first corrected to the zero time point, in
which free fluorophore was eliminated from the gel. This allowed us to correct for
higher fluorescent signals based on the non-covalent dye interactions to the gel and
not the protein. To correct for protein degradation, we normalized our Coomassie
signals to the zero time point in which no degradation could have occurred. These
corrected fluorescent and Coomassie signals were able to be used to gauge relative
conjugation efficiency, taking into account increased protein degradation.
After performing a time course of the reaction at both 37 ℃ and 4 ℃, we were
able to determine very little difference in degredation between either temperature
at early time-points. However, as the reaction was extended to 24 h, greater protein
o
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-

degradation at 37 C occurred, most likely due to an increase in the rate of
50 kDa
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25 kDa catalyst at this temperature, producing a reactive
disproportionation of the Cu(I)
O
3

copper(II) species (Figures 7-9).
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Figure 22. Bioorthogonal Cadiot-Chodkiewicz reactionReaction profile at 4 ℃ over a 24 hr time period. Following
analysis via SDS-PAGE, fluorescent imaging, and staining with Coomassie blue, protein levels were normalized to the 0
time point control. The protein levels indicate minimal to no protein degradation occurs, even at longer time points.
Analysis of coupling efficiency was determined by calculating the ratio of fluorescence to Coomassie staining for each
time point. All reactions were performed in triplicate.

Figure 23. SDS-PAGE of Cadiot-Chodkiewicz time course with pBrPrF containing GFP and at 4°C. As can be seen,
conjugation efficiency increases over time.

Figure 24. . Bioorthogonal Cadiot-Chodkiewicz reaction Reaction profile at 37 ℃ over a 24 hr time period. Following
analysis via SDS-PAGE, fluorescent imaging, and staining with Coomassie blue, protein levels were normalized to the 0
time point control. The protein levels indicate minimal to no protein degradation occurs, even at longer time points.
Analysis of coupling efficiency was determined by calculating the ratio of fluorescence to Coomassie staining for each
time point. All reactions were performed in triplicate.

70

However, for the 4 oC temperature profile the reaction reached approximately 86%
completion in 4h with minimal protein degradation, indicating that the
bioorthogonal Cadiot-Chodkiewicz reaction can be performed quickly and in a
relatively mild conditions. Extended times and temperatures resulted in higher
yields, however were accompanied by protein degradation.
We next sought to explore the effects of an aromatic variant of the pBrPrF. As
such, pBrEtF-GFP151 was expressed, and subjected to identical coupling
conditions at 4 oC in the presence of an alkyne fluorophore. Once again a
successful conjugation was observed as determined by SDS-PAGE (Figure 10).
Lanes

1

2

Figure 25. Bioorthogonal Cadiot-Chodkiewicz reaction using the aromatic pBrEtF UAA contaiing GFP. The reaction
o

performed on GFP (0.2 mg/mL) and AlexaFluor 488 (0.2 mM) in the presence of 5 mM of CuI and 5 mM TEA at 4 C
overnight,. Fluorescence is only observed in the presence of the CuI/TEA system.

Only samples exposed to the CuI/TEA system exhibited fluorescence while
other controls did not, indicating the fluorescence was not due to non-specific
interactions. Interestingly, the use of an aromatic containing bromoalkyne appears
to be less effective in the Cadiot-Chodkiewicz reaction than its aliphatic analog.
Next, we became interested in exploring how the novel biological CadiotChodkiewicz conjugation compared to our previously described Glaser-Hay
reactions. In direct comparison, the Cadiot-Chodkiewicz exhibited far less protein
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degradation as compared to the Glaser-Hay versions of either an aliphatic (pPrF)
or aromatic (pEtF) terminal alkyne containing UAAs.

Figure 26. Coupling profile of the pPrF Glaser-Hay at 4°C. Conjugation yields drastically increase after 6 hr, but are
accompanied by a significant degree of protein degradation.

Furthermore, the data indicates that the biological Cadiot-Chodkiewicz reaction
proceeds at a faster rate than the Glaser-Hay, with the aliphatic version (pBrPrF) of
the coupling reaching completion the fastest in 4 hrs (Figure 12). Gratifyingly,
these results correlate well with the mechanistic understanding of both reactions,
as the Cadiot-Chodkiewicz requires a single copper atom, while the Glaser-Hay
necessitates two copper-alkyne conjugates to form the diyne product. Moreover,
the Cu(I)/(III) redox couple of the Cadiot-Chodkiewicz reaction most likely aids in
the minimized protein oxidation relative to the Glaser-Hay coupling that involves a
reactive Cu(II) intermediate. However, it is important to note that the CadiotChodkiewicz

requires

brominated

UAAs,

requiring

additional

synthetic

preparation. In comparison to other bioconjugation techniques, the Cadiot-
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Chodkiewicz reaction may be slower; however, it employs more synthetically
accessible UAAs and results in a well-defined linear geometry primed for further
reactions. Thus, the selection of the Cadiot-Chodkiewicz reaction may be
dependent on the downstream application and available resources.
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Figure 27. Comparison of alkyne reactions. Reactions were conducted either under the described Cadiot-Chodkiewicz
o

conditions or the Glaser-Hay conditions at 4 C depending on incorporated UAA. Due to differences in protein levels
resulting from oxidative damage, the ratio of fluorophore coupling for each data set was normalized to the 24 hour
time point in order to compare coupling trends between reactions.

Conclusion
Overall, we have demonstrated the successful application of the CadiotChodkiewicz reaction to a biological context. Furthermore, we have demonstrated
that the reaction can be performed with minimal protein oxidation. Finally, we
have demonstrated that the Cadiot-Chodkiewicz variant requires less harsh
copper(I) concentrations, bringing the reaction near the range for in vivo use.
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Future work will involve optimization of conditions to increase the compatibility
of the reaction with biological systems, and extension of the reaction towards in
vivo applications.

Experimental
General All solvents and reagents, including the AlexaFluor 488 Alkyne, were obtained
from Sigma Aldrich or Acros Organics and used without further purification. Plasmids
were provided by the laboratory of Dr. Peter Schultz at The Scripps Research Institute.
Reactions were conducted under ambient atmosphere with solvents directly from the
manufacturer without further purification. All proteins were purified according to
manufacturer’s protocols using a Qiagen NiNTA Quik Spin Kit. Compound purities were
assessed by NMR and found to be 90% or greater for all compounds. All NMRs were
acquired on an Agilent Technologies 400 MHz NMR. MS analysis was conducted on a
Thermo Finnigan LCQ Deca Quadropole Ion Trap via direct injection of samples at 100
µM in a 1:1 H2O/MeOH solution. Unless indicated otherwise, all solutions were
prepared in deionized water (pH ~ 7).
Synthesis of p-bromopropargyloxyphenylalanine (pBrPrF) p-Propargyloxyphenylalanine
(pPrF, 0.050g, 0.150 mmol) was synthesized according to the literature1 , and dissolved
in acetone (5 mL). This solution was then transferred to a vial containing AgNO3 (0.03g,
0.015 mmol) and N-bromosuccinamide (NBS, 0.030g, 0.165 mmol). The mixture was
allowed to stir for 3 hours at room temperature, after which it was diluted with hexanes
(10 mL) and the resulting crystals were filtered off. The filtrate was then evaporated
under reduced pressure and purified via flash chromatography (5:1 hexanes/ethyl acetate)
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yielding the desired product as a white crystal (0.042 g, 0.102 mmol, 68% yield). The
product was then subjected to 1M LiOH in dioxanes (500 µL each) on ice, and then
stirred for two hours at room temperature. The dioxanes were subsequently removed by
rotatory evaporation. Additional deionized water (1 mL) was then added to the product,
and this solution was then brought to a pH = 4 with 6 N HCl. The solution was extracted
in ethyl acetate, dried with MgSO4, filtered, and evaporated under pressure to dryness. A
1 mL solution 2% trifluoroacetic acid (TFA) in dimethylene chloride (DCM) was then
added to the vial, and the mixture was allowed to stir at room temperature for 1 hour,
prior to evaporation under reduced pressure to yield the final product as a yellowish
crystal (0.030g, 0.101 mmol, 99% yield, 67% overall yield). 1H NMR (400 MHz,
CD3OD): δ 7.19 (d, J =8 Hz, 2H), 6.93 (d, J = 8 Hz, 2H), 4.91 (s, 1 H), 4.14 (m 1 H),
3.06 (m, 2 H). 13C NMR (400 MHz, CD3OD): δ 168.4, 155.7, 128.6, 125.4, 113.5, 73.4,
54.4, 52.3, 45.4, 25.4; MS: calcd for C12H13BrNO3: 299.14, found 298.1 and 300.1.

Synthesis of p-bromoethynylphenylalanine (pBrEtF) p-ethynylphenylalanine (pEtF,
0.052g, 0.171 mmol) was synthesized according to the literature protocol2 , and dissolved
in acetone (5 mL). This solution was then transferred to a vial containing AgNO3
(~0.03g, 0.0171 mmol) and N-bromosuccinamide (NBS, 0.034g, 0.189 mmol). The
mixture was allowed to stir for 3 hours at room temperature, after which it was diluted
with hexanes (10 mL) and the resulting crystals were filtered off. The filtrate was then
evaporated under reduced pressure and purified via flash chromatography (3:1
hexanes/ethyl acetate) yielding the desired product as a yellow crystal (0.024 g, 0.063
mmol, 38% yield). The product was then subjected to 1M LiOH in dioxanes (500 µL
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each) on ice, and then stirred for two hours at room temperature. The dioxanes were
subsequently removed by rotatory evaporation. Additional deionized water (1 mL) was
then added to the product, and this solution was then brought to a pH = 4 with 6 N HCl.
The solution was extracted in ethyl acetate, dried with MgSO4, filtered, and evaporated
under pressure to dryness. A 1 mL solution 2% trifluoroacetic acid (TFA) in dimethylene
chloride (DCM) was then added to the vial, and the mixture was allowed to stir at room
temperature for 1 hour, prior to evaporation under reduced pressure to yield the final
product as a yellowish crystal (0.015g, 0.056 mmol, 89% yield, 34% overall yield). 1H
NMR (400 MHz, CD3OD): δ 7.35 (d, J = 8 Hz, 2H), 7.21 (d, J = 8 Hz, 2H), 4.34 (m,
1H), 3.16 (m, 2H), 2.90 (m, 2H). 13C NMR (400 MHz, CD3OD): δ 173.63, 138.42,
132.16, 131.4, 129.2, 79.2, 54.6, 37.2, 27.22; MS: calcd for C11H11BrNO2: 269.12,
found 268.1 and 270.1.

Expression of UAA-containing GFP-151 Escherichia coli BL21(DE3) cells were cotransformed with a pET-GFP-TAG-151 plasmid (0.5 µL) and a pEVOL-pCNF plasmid
(0.5 µL) using an Eppendorf electroporator. Cells were then plated on LB-agar plates
supplemented with ampicillin (50 mg/mL) and chloramphenicol (34 mg/mL) and grown
at 37℃. After 16 h, a single colony was selected and used to inoculate LB media (4 mL)
supplemented with ampicillin and chloramphenicol. The culture was grown to confluence
at 37℃ over 16 h. This culture was then used to initiate an expression culture in LB
media (20 mL) at OD600 = 0.1, then incubated at 37℃ until an OD600 ~0.7 was
obtained. At this point, the cells were then pelleted at 4℃ at 5000rpm for 10 mins. The
supernatant was removed and the cells were gently resuspended in 4 mL of LB media.
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Ampicillin and chloramphenicol (4 µL each), 1M IPTG (4 µL), 20% arabinose (4 µL),
and 100mM of the UAA (40 µL) were then added. Induced cells were grown for an
additional 16 h at 37℃, then harvested via centrifugation (10 min at 5000 rpm). The
media was decanted and the cell pellet was placed in the -80℃ freezer for 20 min.
Purification of the UAA-containing GFP was then performed using commercially
available Ni-NTA spin columns according to the manufacturer’s protocol. Protein yield
and purity was then assessed by SDS-PAGE and spectrophotometrically by Nanodrop
spectrophotometry. Protein was then transferred into phosphate-buffered saline solution
(PBS, pH = 7) using 10k MWCO spin columns prior to use in the biological CadiotChodkiewicz coupling.

General Protocol for the Biological Cadiot-Chodkiewicz Coupling To a sterile 1.5 mL
Eppendorf tube, the following was added in order: 10 µL of bromo-alkyne UAAcontaining GFP151 (~0.5 mg/mL), 5 µL of a vigorously shaken CuI solution (50 mM), 2
µL of trimethylamine (TEA, 50 mM), 5 µL of 488-Alexafluor alkyne (1 mM in DMSO),
and 3 µL of PBS (pH = 7). Control reactions were set up in the absence of CuI and TEA
and with the addition of a total of 10 µL of PBS. Reactions were performed at various
temperatures and times as indicated in the main text, with the 4℃ for 6 hr variant being
the ideal reaction conditions. Denatured SDS-PAGE were run following reaction, without
cleaning or condensing the reaction, as it was found that the fluorophore would run off
the gell and stil allow for adequate imaging.
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General Protocol for the Biological Glaser-Hay Coupling To a sterile 1.5 mL Eppendorf
tube, the following was added in order: 10 µL of termainl alkyne UAA-containing
GFP151 (~0.5 mg/mL), 5 µL of a vigorously shaken CuI solution (500 mM), 2 µL of
trimethylethylenediamine (TMEDA, 500 mM), 5 µL of 488-Alexafluor alkyne (1 mM in
DMSO), and 3 µL of PBS (pH = 7). Control reactions were set up in the absence of CuI
and TMEDA and with the addition of a total of 10 µL of PBS. Reactions were performed
at 4℃ for various times as indicated in the main manuscript. Denatured SDS-PAGE were
run following reaction, without cleaning or condensing the reaction, as it was found that
the fluorophore would run off the gell and stil allow for adequate imaging.
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CHAPTER 4: USING UAAS TO ILLUSTRATE AND ALTER PROTEIN
STRUCTURE-FUNCTION RELATIONSHIPS

Part I: Utilizing Unnatural Amino Acids to Illustrate Protein Structure-Function
Relationships: An Experiment Designed for an Undergraduate Biochemistry Laboratory

A learning outcome in most biochemistry courses is instilling an understanding of
protein structure-function relationships. In order to master this concept, students must be
able to recognize how changing even a single amino acid in the protein’s primary
sequence directly impacts the structure of the protein. Moreover, linked to this concept is
the central dogma, a core tenant of any molecular biology or biochemical program. To
understand how alterations in a protein’s primary sequence arise, students must recognize
that the genetic material coding each amino acid of a protein is stored in the DNA. This
DNA then gets transcribed into RNA, which is ultimately translated into the amino acid
sequence. Thus, an understanding of protein structure and function is intrinsically tied to
an understanding of the central dogma. That being said, it is often difficult to illustrate
this connection in a purely classroom setting. Consequently, we have developed a
laboratory experiment to highlight these connections simultaneously.
Unnatural amino acids (UAAs) represent a unique means to convey all of these
concepts.1,2 In particular, the ability to introduce novel chemical functionality unavailable
in the 20 canonical amino acids allows students to observe how altering amino acids can
affect the microenvironment around an amino acid residue, drastically affecting how the
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protein folds and behaves. This represents an advantage over simply changing one
naturally-occurring amino acid for another, as these changes tend to be more nuanced,
and thus make it harder for students to fully comprehend the chemical alteration they
have performed. Furthermore, utilization of the Schultz methodology of UAA
incorporation, whereby successful incorporation of a UAA hinges on the suppression of a
TAG point mutation, encourages students to engage with the transcription and
translational processes (Figure 1).1–3 In doing so, they can better visualize how mutations
at the DNA level are carried through into a protein’s final structure and function.
Moreover, due to the necessity to introduce orthogonal translational machinery (a tRNA
and aminoacyl tRNA synthetase pair capable of recognizing and charging the UAA to the
tRNA), the laboratory also provides a mechanism to introduce multiple molecular cloning
techniques to the students.3 Moreover, the use of UAAs in biological chemistry is
becoming increasingly prevalent in multiple applications (therapeutics, bioconjugates,
protein probes, etc), and thus exposing students to this valuable technique has
pedagogical advantages beyond the scope of the laboratory.
Herein we report a laboratory that uses the Schultz methodology to incorporate
commercially available UAAs into Tyr66 of green fluorescent protein (GFP; Figure 1).
This tyrosine, along with Ser67 and Gly68, is essential in fluorophore formation, and thus
is directly linked to protein function.4,5 Consequently, students can directly visualize the
alteration in UAA structure as a change in the GFP fluorescence spectrum, illustrating
how protein function is altered by relatively minor changes to the amino acid sequence.
Furthermore, compared to other methods to illustrate structure-function relationship using
GFP, such as PCR mutagenesis, the Schultz methodology employing UAAs is more
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direct and requires less genetic manipulation on the part of the student given the time
constraints of a laboratory setting.5,6 As a result, it is more likely to produce a functional
mutated-protein product, and therefore concretely illustrate for the students the effects of
altering even a single amino acid on protein function.
O
N

R
Tyr66

O

N
N
H

OH
Figure 28. Structure of GFP fluorophore. Tyrosine-66 (green) will be replaced with different unnatural
amino acids to alter spectral properties.

Learning Objectives
The utilization of UAAs is a cutting edge technology, and is an excellent mechanism
to foster discussion involving protein structure-function relationships. To the best of our
knowledge, there has been no reported undergraduate teaching lab incorporating UAA
technology.7,8 As a result, we sought to generate a simple and inexpensive laboratory
exercise that would introduce students to this rapidly expanding technology while
simultaneously reinforcing the principles of protein structure and function and the central
dogma.

Moreover,

this

laboratory

confers

practical

experience

in

bacterial

transformation, protein expression, protein purification, and fluorescence spectrometry.
The laboratory also seeks to solidify key concepts from the classroom, specifically
involving translational processes.
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Overview
In this experiment the expression and purification of a UAA-containing GFP as well
as a wild type GFP will be performed. While typically a unique aminoacyl-tRNA
synthetase (aaRS) must be evolved for a specific UAA, recent reports have demonstrated
that the pCNF aaRS is capable of incorporating up to 20 different UAAs.9 This is optimal
for this experiment to minimize the storage, purification, and organization of multiple
aaRS plasmids. The other requirement for UAA incorporation is a gene containing a
TAG codon at the residue desired for UAA incorporation, allowing for the suppression of
the stop codon by UAA integration if the system is properly functioning. Using plasmids
harboring the previously reported promiscuous aaRS, pCNF aaRS, and GFPTAG66,
students will perform a co-transform of competent E. coli. This can be accomplished by
either electroporation or chemical transformation with competent cells, facilitating
discussions on mechanisms of bacterial transformation, transformation efficiency, and the
requisite antibiotics to facilitate plasmid uptake and maintenance. The transformed cells
will then be used to induce GFP expression in the presence of an assigned UAA.
Depending on laboratory size, each pair of students may be assigned a different
commercially available UAA. Additionally, students will transform and express wildtype GFP for comparison of the fluorescence emission profile of their UAA-containing
GFP versus the wild-type. All plasmids required for the experiment are available from
Addgene (Plasmid #48215), or can be obtained from the authors, and the UAAs are all
commercially available.
Protein purification may be carried out by numerous methods. Hydrophobic
interaction columns, which are commercially available and simple for the undergraduate
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student, will be used to partially purify both UAA-containing GFP and wild-type GFP.
Our results indicate that this procedure affords GFP in good yield with only minor
contaminants, and with approximately no effect on the fluorescence profile of the
protein.9
This experiment will incorporate several key biochemistry laboratory skills for the
undergraduate researcher including electroporation, protein expression and purification,
fluorimetry, and UAA-mutagenesis.

Laboratory Set-Up and Procedure
A wild-type GFP transformation and expression protocol was adapted from the
commercially available pGLO plasmid kit (Bio-rad; Cat # 166-0003EDU).
UAA-mutagenesis using the Schultz methodology requires the preparation of plasmid
stocks harboring the pEVOL-pCNF-aaRS plasmid with chloramphenicol-resistance, the
pET-GFPWT plasmid with ampicillin resistance, and the pET-GFPTAG66 plasmid with
ampicillin resistance. Additionally, 100mM stocks of p-azidophenylalanine (pAzF), pbiphenylphenylalanine (pBiPhF), p-acetylphenylalanine (pAcF), p-iodophenylalanine
(pIF) in deionized water should be prepared prior to the start of the laboratory period (see
Experimental).
Students work in pairs over the course of three weeks, and require typically two-hours
for each lab meeting. Week 1 of the laboratory focuses on bacterial transformation, and
mutant GFP expression. Week 2 involves both wild-type and mutant GFP purification
and fluorescence. Week 3 entails a “GFP symposium” facilitating discussion about the
techniques utilized in lab and student presentations.
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Week 1
On the first week, students perform the transformations and induce expression of GFP
mutants harboring an unnatural amino acid. The chemical transformation of pET-GFPWT
are performed in direct accordance with the Bio-Rad pGLO kit (substituting 1 mM IPTG
for arabinose in the agar plates). This plasmid encodes the wild-type GFP and does not
require the aaRS machinery. The plasmid can also transformed by electroporation to
provide a direct comparison to the chemical transformation. This portion of the lab
emphasizes the transformation of plasmid DNA into E. coli for heterologous expression.
If available, students may also perform an optional double transformation using 0.5 µL of
pEVOL-pCNF plasmid and 0.5 µL of pET-GFPTAG66 plasmid, both at approximately 100
ng/µL with an electroporator at 1800V. These transformations should be recovered at 37
o

C for 1 hr, then plated on plates containing ampicillin and chloramphenicol.
While transformations are being performed, students also induce the expression of a

mutant GFP with their specified UAA using a second bacterial culture that was
previously prepared. Two days prior to the laboratory, the instructor must co-transform
the pEVOL-pCNF plasmid and pET-GFPTAG66 as described above. The next day, a
colony should be selected and grown in 10 mL of LB Media containing ampicillin and
chloramphenicol at 37 oC overnight. The day of the lab, approximately 1-2 hours before
the scheduled time, a 10 mL expression culture of the cells should be innoculated for
each group at OD600 0.1. During the actual laboratory students will begin expressing their
UAA-containing GFP using an expression culture that has grown to log phase (OD600 =
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0.6 – 0.8). Expression of the GFPTAG66 is induced with the addition of 10 µL each of
1000x stocks of IPTG and 20% arabinose. Also, at this time students add 100 µL of their
assigned 100 mM UAA stock. This laboratory period facilitates a discussion of typical
transformation procedures (students are exposed to both heat shock and electroporation in
the exercise) as well as a discussion of molecular genetics for gene expression. Finally,
the use of the Schultz methodology for incorporation of the UAA into GFPTAG66
facilitates a discussion of gene transcription and protein translation.
The next day the laboratory supervisor centrifuges the expression cultures of the
UAA-containing GFP (5000 g for 10 min). The cell pellets are then stored at -80 oC until
the next laboratory session. Additionally, at some point in-between lab periods students
observe the fluorescence of the E. coli cell pellet, and count the colonies on their
transformation plates. This allows them to identify the differences between
electroporation (UAA plasmids, and possibly the wild-type plasmid) and heat-shock
(wild-type plasmid), as well as single and double transformations. These colony counts
are used to calculate the transformation efficiency for the single transformations versus
the double transformations.
Week 2
In the second week students use hydrophobic interaction columns (HIC) to purify
both their wild-type and UAA-containing GFP. This week follows the protocol described
in the Green Fluorescent Protein Chromatography Kit (Bio-Rad; Cat # 166-0005EDU).
Using their partially purified protein at a concentration of 0.5 to 1 mg/mL, students
prepare a sample for fluorescence detection by diluting 10 µL of their protein in 3 mL of
1 x PBS. Students then observe the fluorescence spectra of their wild-type and UAA-
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containing GFPs using a fluorimeter set to excite at 395 nm and scan between 410 nm to
600 nm.
This week also has the potential to facilitate a discussion on protein purification
techniques, as the HIC process pulls down many contaminating proteins along with the
UAA-mutated GFP. As such, column fractions can be analyzed via SDS-PAGE and
stained with Coomassie blue to highlight the limitations of this purification technique
(see Figure 2).

Figure 29. Coomassie stained SDS-PAGE of the UAA-containing GFP66 produced by the biochem students. The gel
highlights that the hydrophobic interaction column is an adequate means to purify the GFP and facilitates a
conversation about what the properties of the other contaminants. Our fluorescence data indicates that the
contaminants did not affect the spectra.

Furthermore, if time is not available to stain and destain with Coomassie blue, the GFP
fluorescence can be directly observed through the SDS-PAGE gel using a UV
transluminator or lamp (see Figure 3).
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Figure 30. Fluorescent imaging of SDS-PAGE of the UAA-containing GFP66 produced by the biochem students. Gel was
excited at 302 nm for optimal fluorescent detection of all UAA-variants. Samples were treated with a 2x SDS-dye mix
prior to loading, which retained protein structure allowing for the detection of the GFP via fluorescence, and thus
obviating the need for Coomassie staining.

Week 3
In the third week students present their results as well as a discussion of topics related
to protein expression, purification, and fluorescence. Each student is assigned a specific
topic to prepare a 5-10 min presentation. Examples of topics include: biological relevance
of lysozyme, methods of cell lysis, DNA mutagenesis for the introduction of the TAG
codon, aaRS evolution, mechanism of chemical transformations, antibotics and antibiotic
resistance, protein induction by IPTG/Arabinose, vectorology, the chemical basis of GFP
fluorescence, and numerous other topics related to the laboratory. Additionally, the
results of the laboratory are discussed and compiled fluorimetry data is presented to truly
illustrate the effect of the different amino acids on GFP fluorescence

Results and Discussion
Overall, the experiments described above translated well in a laboratory setting.
While the traditional pGLO GFP lab has been employed in our Advanced Biochemistry
Laboratory for the past several years, the unnatural amino acid component has been
included in the past two years. Each year averages between 8-12 students in the lab, for a
total of approximately 20 total student participants. The double transformations that the
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students performed yielded approximately 5 colonies per lab group, which is to be
expected of double transformations. Single transformations afforded much higher
transformation efficiencies, to those referenced in the literature and ranged from 0 to 109
cfu. The efficiencies were typically student dependent based on previous experience and
their ability to follow directions. These results promote discussions into antibiotic
resistance and requisites for colony growth on antibiotic plates. Protein expression levels
were robust, the GFPWT and the UAA-containing GFP66 both yielding between 0.5 to 1
mg/mL of purified protein.
The UAA-mutagenesis of the GFP66 was successful for all UAA used in this
laboratory, as demonstrated by the successful shift in the UAA-containing GFP66 relative
to the GFPWT. Gratifyingly, spectral shifts of GFP fluorescence were observed for each
mutant, demonstrating the relationship between protein structure and function, and the
influence of a single amino acid mutation (see Figure 4). The most dramatic blue shift
was observed for the pAcF mutant, most likely due to the resonance into the carboxylic
oxygen. Overall, students were able to effectively transform bacteria with the plasmids,
as well as express and purify functional protein, and analyze its spectral properties.
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Figure 31. Fluorescence results for the expression of GFP mutants. (A) Fluorescence spectra obtained on a fluorimeter
exciting at 395 and scanning emission from 410 to 600 nm. (B) Visualization of mutant protein fluorescence on a
transluminator with an excitation wavelength of 365 nm.

This experiment was piloted in an upper-level biochemistry lab targeted for juniors
and seniors with a background in the subject. Compared to a standard protein
expression/purification lab, in which students transform GFPWT into E. coli and
subsequently purify the protein, this exercise provides students with exposure to
considerably more biochemical and molecular biology techniques. In particular, the use
of the Schultz methodology for UAA incorporation allowed students to engage with
topics from lecture, such as translation and protein structure-function relationships, in a
way that was not accessible via a more traditional lab (Table 1). Based on student
evaluations of the laboratory, an appreciation of how the experiment concretely illustrates
protein structure-function relationships was the most powerful learning outcome.
Moreover, the use of the fluorimeter allowed students to visualize the impact of their
UAA incorporation, thereby reinforcing how even a single amino acid alteration can
drastically impact a protein’s function. This concept is perfectly illustrated by the
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integration of UAAs into the laboratory and can easily be achieved over the course of 2
lab meetings.
Table 3. Comparison of Standard GFP Laboratories Versus the UAA Laboratory
Learning Outcomes for Standard GFP
Learning
Outcomes
for
UAATransformation Experiment
Mutagenesis of GFP Experiment
• Basic understanding of transformation • All those listed in the “Standard” GFP
techniques as well as protein purification
Transformation Experiment
(which obviously pairs well with protein
properties).
•

Provides student with an opportunity to
understand
selection
processes
in
conjunction with plasmid design (i.e.
antibiotic resistance as a means to ensure
plasmid maintenance).

• Facilitates discussion of translational
processes via the Schultz’ methodology for
UAA incorporation

•

Provides an illustration of molecular
genetics by providing a means to discuss
operators and promoters

• Facilitates discussion of protein structurefunction relationship, as the incorporation
of different UAAs alters the GFPchromophore, affecting fluorescence profile
• Provides students with the opportunity to
practice use of a fluorimeter, a standard
laboratory instrument in most chemical
settings. Also facilitates a discussion of
fluorescence, a topic typically relegated to
physical chemistry
• Provides students with exposure to current
technologies (e.g. UAA incorporation) that
are widely employed within the field of
chemical biology.

The experiment also provides practical introductions to bacterial transformations and
illustrates the differences in transformation efficiency between various protocols.
Additionally, the necessity for double-transformations facilitates discussions for
mechanism of antibiotic resistance and the necessity of antibiotic resistance onto the
plasmids to facilitate bacterial selections. Finally, key aspects of fluroimetry are also
introduced in the experiment as differing functional groups result in spectral shifting of
the fluorophore emission.
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Upon completion of the laboratory during week 3, the learning outcomes were
assessed both by presentation projects and by a laboratory evaluation form (see
Experimental). Students were asked to distil the big picture ideas as well as assess the
effectiveness of the laboratory. Overall, students were overwhelmingly positive in the
assessment of the lab and all of the students were able to clearly and concisely
communicate both the purpose of the lab and fundamental concepts about plasmids and
protein translation. Finally, learning outcomes were assessed by the completion of a
typical laboratory report summarizing the experiment and the overall results for each
student.

Conclusion
Unnatural amino acids are an excellent mechanism for the study of protein structurefunction relationships. This developed laboratory for an upper division biochemistry
course provides a simple means of demonstrating this feature of UAAs. Moreover, the
mechanism of UAA incorporation facilitates substantial learning and solidifies several
key concepts including: bacterial transformations, molecular cloning, and fluorescence.
Experimental
Experimental Handout Adapted for Laboratory Exercise – Week 1
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Experiment 4 – Transformation of E. coli with the gene for Green Fluorescent Protein
(GFP)
Week 1 – Transformation of E. coli, plating and calculations of transformation efficiency,
and protein expression
Week 2 – Purification of GFP by
column
chromatography
and
fluorescence measurements.
Background:
Unnatural amino acids (UAAs)
allow scientists to expand the
rather
limited
biochemical
functionality found in the 20
Figure 1. Mechanism for genetic incorporation of unnatural amino acids.
An orthogonal synthetase must be introduced that does not cross-react
with any natural tRNA or amino acid. This is coupled with a new tRNA that
harbors
95an anticodon for the TAG codon. When the ribosome encounters
the TAG codon, a new amino acid is incorporated, rather than the
discontinuation of translation. Adapted from Chem. Biol. 2009 16, 323-

canonical amino acids and introduce novel reactivity not typically found in proteins1,2.
Incorporated via suppression of a TAG stop codon in translation, which can be
introduced into the DNA at a desired residue position of the target protein. In order to
incorporate UAA’s, the cell needs to be supplied with new orthogonal machinery (so that
there is there is no cross-talk between the endogenous translation machinery of the cell
and the machinery necessary to incorporate the UAA). A foreign aminoacyl-tRNA
synthetase (aaRS) must be expressed in the cell that will recognize the UAA and
“charge” it to an exogenous tRNA with the antisense codon for TAG. Now, as the cell’s
translation machinery reads our desired protein’s mRNA, it will incorporate the UAA in
any codons that code for TAG (thankfully the TAG, or Amber, stop codon is rarely used
in E. coli, and therefore this new machinery will not impact cell viability/normal
functioning). Scientists can readily manipulate the DNA to introduce TAG stop codons
into desired residue positions on the protein’s DNA. Overall, this process allows for the
site-specific incorporation of UAA’s in pre-defined positions. Figure 1 provides a great
overview of the new cellular machinery described above. The alteration of a single amino
acid can have significant impact on protein function. This week, we will introduce
UAA’s in place of Tyrosine 66 in Green Fluorescent Protein (GFP). Position 66 is a
residue essential in the formation of the GFP fluorophore. Based on the properties of the
incorporated UAA, the fluorescence of GFP will change. We will employ one of several
commercially available UAAs, and each laboratory group will be assigned an amino acid.
While typically, a unique aaRS must be evolved for an individual amino acid, recent
work has found that the pCNF-aaRS is promiscuious and able to recognize multiple
different UAAs, a property that we will exploit for UAA incorporation. We will be
measuring these altered fluorescence spectra after purification of the protein in Week 2.
Helpful definitions
Competent cells: Capable of taking up plasmid DNA. Typically, cells are treated with
calcium chloride which alters their membrane in such a way that DNA can pass through.
Transformation: Once the bacteria have taken up endogenously added DNA, they are
called "transformed."
LB plates – contain agar and a nutrient broth named after Luria and Bertani.
LB/amp plates – contain LB growth media, agar and ampicillin
LB/amp/ara plates – contain LB growth media, agar, ampicillin and a sugar inducer
called arabinose
Transformed E. coli will grow on LB/amp plates; ampicillin is an antibiotic similar to
penicillin. Transformed bacteria will express an enzyme that is capable of destroying the
ampicillin present in the plate media. Thus, only those bacteria will grow on LB/amp
plates. However, to express GFP, an inducer must be present as well. Thus, GFP should
only be expressed on LB/amp/ara plates.
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UAA – unnatural amino acid
aaRS- aminoacyl-tRNA synthetase, a protein responsible for charging tRNA molecules with
specific amino acids
pEVOL-pCNF – a plasmid coding for the tRNA synthetase that recognizes our UAA, as well as
the tRNA with an antisense codon for TAG. This plasmid gives the bacteria resistance to
chloramphenicol.
pET-GFP-66-TAG – a plasmid coding for GFP with a TAG codon in residue 66. This plasmid
gives the bacteria resistance to ampicillin.
Transformation procedure
This week you will be performing two transformations. One will be a single
transformation and will produce the wild-type GFP. The second transformation will be a
double transformation involving two plasmids, and will involve the electrical shock
(electroporation) of competent cells to introduce both the GFP protein (with a mutated
TAG codon at position 66) and the necessary translational machinery.
The procedure for transforming E. coli is very simple and is described in the
“Transformation Kit-Quick Guide.” You will use 10 µl of the pET-GFP-WT plasmid
solution provided. We will use Pipetmen to dispense solutions because they are more
precise than the plastic pipets shown in the “Transformation Kit-Quick Guide”. There are
a few changes to the kit procedure that I will announce in lab before we begin the
procedure.
For the electric shock transformation, all of the following must be placed on ice: an
aliquot of competent cells, some media, an electrocuvette, pET-GFP-66-TAG plasmid,
and pEVOL-pCNF. The process is as follows:
NOTE: to allow you to move faster, it is useful to preset and place pipet tips on all
the pipetmen that you will be using.
1) Take up 0.5 µL of pEVOL-pCNF – inject this into the aliquot of cells
2) Take up 0.5 µL of pET-GFP-66-TAG – inject this into the aliquot of cells
3) Take up all 50 µL of the cells (set pipette to 55uL to ensure you get the full
volume) –and then transfer the full volume to the electrocuvette (NOTE: the
opening for the electrocuvette is very slim, so do your best to make sure that the
very tip of the pipette-tip is in between the slot).
4) Place the now-full electrocuvette into the electroporator, which should be preset to
1600V. Shock your cells!
5) RAPIDLY add 500uL of chilled media to the cells – this will help them recover
from the shock.
6) Transfer the ~550uL of transformed cells to a labeled eppendorf tube and allow to
recover for 1 hr at 37 oC.
If your cells “spark/arc”: Redo the procedure above, using 0.4uL of DNA each (for a
total of 0.8uL of DNA) and shock the cells at 1400V.
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After the 1hr recovery, plate a 100 µL aliquot of the transformed cells onto an
AMP/CHLOR LB Agar plate.
YOU MUST CHECK YOUR PLATES TOMORROW AFTERNOON FOR
COLONIES!
Expression Protocol:
Additionally, you will set up a protein expression that you will purify next week. Protein
expression is an extremely time dependent process, as expression must be induced at an
optimal time in the cell growth cycle to maximize yield. Prior to lab, your instructor has
inoculated a liquid culture of LB media (containing ampicillin and chloramphenicol) with
the bacteria containing both the pEVOL-pCNF plasmid and the pET-GFP-66-TAG
plasmid.
1)
Monitor the growth of the cells by measuring the OD600 of the bacterial
culture on the spectrophotometer (this may require you to make a 1:10 dilution of
the cells prior to measurement)
2)
When an OD600 of 0.8 has been achieved, obtain 10 mL of bacterial
culture and induce GFP production by the addition of 10 µL of 20% arabinose (to
induce the production of the translational machinery), 10 µL of 1M IPTG (to
induce the production of GFP), and 100 µL of an assigned unnatural amino acid
(100 mM).
3)
The culture will now be placed in an incubator at 30 oC for 16 h to allow
for protein expression.
4)
Your instructor will centrifuge the culture tomorrow at 4,000 rpm for 10
min, discard the supernatant, and store the cell pellet at -80 oC for you to use next
week in the GFP purification.
Things to do:
1. Check for transformed E.coli on the thermal transformations of wild-type protein
LB/amp and LB/amp/ara plates. Check all plates with the UV light to look for “glowing”
GFP containing colonies.
2. You will count the total number of colonies on the LB/amp and LB/amp/ara plates.
With these numbers, you can calculate transformation efficiency. We will go over this
calculation in lab.
3. Observe your UAA GFP pellet for fluorescence using the transilluminator.
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Experimental Handout Adapted for Laboratory Exercise – Week 2
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Experiment 4 Week 2– Bacterial cell lysis and partial purification of GFP by
hydrophobic interaction chromatography
Please follow the instructions below. The GFP purification quick guide is posted but I
have made significant changes. Use Pipetmen for all volume transfers. Green fluorescent
protein (GFP) will bind to a hydrophobic interaction column(HIC) in the presence of 2 M
ammonium sulfate (hydrophilic proteins will not bind. Then we elute GFP from the HIC
with a buffer of lower salt concentration.
Solutions used:
TE buffer – 10 mM Tris, 1 mM EDTA pH 8.0
Binding buffer – 4 M (NH3)SO4 in TE;
TE Column Equilibration buffer - 2 M (NH3)SO4 n TE
Column Wash buffer -1.3 M (NH3)SO4 In TE
Lysozyme in TE buffer
Bacterial cell lysis
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1. Each student will receive a 2 ml portion of bacterial culture. The cells will have been
grown (name that verb tense!) for 24-36 hours at 30 °C with shaking. Look at the cell
suspension under UV light. Does it glow?
Observation: ____________________________________________________
2. Spin the cells in a microfuge tube for 5 minutes at maximum speed to obtain a pellet.
Since there are 2 mL, I suggest you pipet 1 mL into a microfuge tube, spin for 5 minutes,
decant the supernatant and then add the second ml of bacterial culture. Spin again for 5
minutes and decant the supernatant.
3. Resuspend the cell pellet in 250 µl TE buffer by pipetting up and down several times.
Modified lysozyme step – lysozyme degrades the cell wall. Then freeze/thaw cycles
should “finish the job.”
4. Add 100 µl lysozyme solution to the resuspended cells. Incubate the sample at 37 °C
for 30 minutes. Be sure to vortex the sample about every 5 minutes during the 30 minute
period.
5. Freeze the sample in liquid nitrogen to rupture the cell walls. Thaw quickly in warm
water. Repeat the freeze/thaw cycle.
6. Spin the sample for 10 minutes at maximum speed to pellet the insoluble bacterial
debris.
While the tubes are spinning, prepare the HIC column (see below)
Page 2 of 2
After the spin, carefully pipet the supernatant into a new, clean microfuge tube. Look at
the pellet and the supernatant under UV light.
Observations:
pellet _________________________________________________
supernatant __________________________________________________
The total volume is now 350 µl, so add 350 µl binding buffer, 4 M (in TE, before loading
the column.
Final concentration of (NH3)SO4 =_________________________________
You will load ALL 700 µl onto the column.
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7. Column prep and loading
You will need 3 tubes for collecting fractions from the column. Label them 1, 2 and 3.
Clamp the HIC column in an upright position. Remove the top and bottom caps and allow
the column to drain (into a waste beaker). Prepare the column by adding 2 ml
Equilibration buffer (2 M (NH3)SO4 in TE) to the top of the column. After it has drained
through, re-cap the column and place collection tube 1 under it.
8. Load your entire supernatant sample (700 µl) on the column bed carefully. Allow the
supernatant to drip down the side of the column wall so as not to disturb the HIC column
bed.
9. Uncap the column and allow the column to drain slowly. It is during the loading step
that the column packing material (HI resin) and the GFP “find each other” so you do not
want to rush this step.
Check fraction 1 under UV light. Observation
______________________________________
10. Place tube 2 under the column. Apply 700 µl Column Wash solution (1.3 M
(NH3)SO4 in TE) to the top of the column. Collect as fraction 2.
Check fraction 2 under UV light.
Observation ______________________________________
11. Place tube 3 under the column. To elute GFP, apply 700 µl TE buffer. Collect as
fraction 3. Check fraction 3 under UV light.
Observation ______________________________________
Label your GFP column fractions with your initials and place them in the designated rack
before you leave. Did you check them with the UV lamp to see if they GLOW?? Really?
Who will have the highest yield of GFP??
12. Record the emissions spectrum of both the WT GFP sample and the mutant GFP
sample on the fluorimeter
1)
2)
3)
4)

Turn on the fluorimeter and let it warm up.
To a quartz cuvette, add 10 uL of GFP into 3 mL of (TRIS OR PBS)
Place into holder in the fluorimeter
Operation of fluorimeter software
a.
Open FL WinLab
b.
Pick any scan method
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c.

d.
e.

A window will pop up – select the heading titled “Emission”
i.
Parameters: start (nm): 405; end (nm): 650; excitation
(nm): 395; ex slit (nm): 10; em slit (nm): 10; scan speed (nm/min):
50
Name the file a 4 letter name for your group (EX: GRPA)
Press the “go” on the stop light to begin the read

Experimental Report Guidelines – End of Lab
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Experiment 4 Report and oral presentation guidelines
Written report
1.
Write a brief summary (one paragraph) of the goals of the two-week
experiment and the outcome.
2.
Note anything unusual that may have happened.
3.
Week 1 – report the results of the transformation. In a table, summarize
what you saw on the 4 plates. Also explain why some colonies expressed GFP
and others didn’t. Show calculations of transformation efficiency. Remember:
Transformation efficiency is the number of colonies/amt of DNA used. If you saw
nothing on the plates, explain why.
4.
Week 2 – report the results of the purification of GFP from the bacterial
culture. Why did the protein bind to the column? Do you think it was pure? How
would you check? Discuss the observed fluorescence spectra. Was there a
difference between the UAA protein and the WT protein?
The entire written report need not be more than 1-2 pages.
In addition to presenting the report information (especially #3 above), each of you will
also answer a question. You should think of it as “teaching the rest of the class” about a
particular topic related to the two-week GFP experiment. That means that you should
prepare figures with essential chemical structures or be willing to draw them on the
board. Total presentation time should be 7-8 minutes/student. Questions from the
audience are encouraged. If you don’t ask them of each other, I definitely will. Heck, I
probably will anyway.
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Student 1
We used lysozyme and freeze/thaw cycles to rupture the bacteria. How does lysozyme
work? What other methods could we have used to lyse the bacteria without destroying
GFP?
Student 2
Explain how the “heat shock” procedure for transforming bacteria works (this was week
1). What is the purpose of the CaCl2 transformation solution? What are other common
methods to get plasmid DNA into bacterial cells?
Student 3
How is the GFP fluorophore formed (see the J. Chem. Ed. article)? This may require you
to look at the sequence/structure of GFP. Is there any reason why this protein evolved?
Student 4
In the J. Chem. Ed. article posted on Blackboard, the researchers explain the amino acid
mutations in GFP that have been done and how those mutations affect the
fluorescence/color of the resulting GFP proteins. Using the amino acid sequences, the
article and what you know about chemistry, explain the color changes. (It is essential that
you show the class the sequences in Table 1.)
Student 5
Explain how site-directed mutagenesis of GFP was performed to make the mutants
described in the J. Chem. Ed article posted on Blackboard and used in the experiment.
Student 6
How does arabinose induce expression of GFP? (Be sure to include the structure of
arabinose) Compare the arabinose induction system with the lac operon.
Student 7
What is the chemical mechanism of ampicillin resistance? Compare the structures of
ampicillin and penicillin. This will require some explanation of the structure of the
bacterial cell wall.
Student 8
What is the drug Augmentin? Provide some information about the structure and
mechanism of the enzyme, Β-lactamase that destroys ampicillin. What other inhibitors of
Β-lactamase are available? Or under development? Tell us about at least one more.
Student 9
Explain how hydrophobic interaction chromatography works. Be sure to explain the
purpose of the buffers used (equilibration, binding, wash and TE). If you used ion
exchange chromatography, under what conditions, if any, would you expect GFP to bind
to the column? This may require you to look at the sequence/structure of GFP.

105

Student 10
Explain the process of incorporating unnatural amino acids into proteins. How are
synthetases evolved to recognize unnatural amino acids?
Student 11
Explain the basis of polyspecificity of a synthetase. How else have unnatural amnio acids
been employed than to alter the fluorescence of GFP (pick 1-2 examples).

You may use PowerPoint or write on the board. If you have any questions about the
written report or the presentation, please ask!
The complete pdf guidebooks (50-60 pages) for the two GFP experiments that you did
are posted on Blackboard under course documents. You need not print out the whole
thing but you will find the majority of the information you need to answer the questions
there.
References
1
Liu, C.; Schultz, P. “Adding new chemistries to the genetic code” Annu. Rev. Biochem.
2010, 79, 413-44.
2
Young, T.; Schultz, P. “Beyond the canonical 20 amino acids: Expanding the genetic
lexicon” J. Biol. Chem. 2010, 285, 11039-11044.
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Evaluation form used to gather student feedback
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Lab Evaluation Form
Unnatural Amino Acids and GFP

The purpose of this evaluation is to gather input so that we can improve this lab and your
learning outcomes. Please answer these questions without referring to the lab manual.
Your response will be kept anonymous and are not graded. Thank you for participating!
Your Name _________________________
1. What is the purpose of having 2 plasmids? What proteins are specifically encoded on
each?

2. Summarize the major findings of this lab.

3. What is the strongest feature of this lab? In other words, what contributed most to your
learning?
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4. Was bringing unnatural amino acids into the lab useful?

5. Do you have any additional comments about this lab?

List of Chemicals Used in Laboratory Exercise

Chemical

4-iodo-L-

CAS

4-acetyl-

Density

(g/mol)

(g/mL)

242 •

Potential irritant

207.23

1.226

Potential irritant

155760-02-4

241.2896

---

Potential irritant

33173-53-4

206.2

---

Potential irritant

50-85-9

22888-49-9

29

Hazard

---

•

phenylalanine

MW

1.09

phenylalanine
L-4,4’biphenylalanine
4-azido-Lphenylalanine
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isopropylthio-βgalactoside

1552

238.32

---

Potential irritant

532

150.13

---

Potential irritant

403.45

---

allergies

56-

323.13

---

irritant

79-

71.08

---

neurotoxin

9-019

L-(+)-arabinose •
8-37-0

ampicillin

7177-48-2

chloramphenicol•
75-7

acrylamide •
06-1

Instructor Prep Guide
Week 1 – Transformation of E. coli, plating and calculations of transformation efficiency,
and

protein expression

To prepare (beyond the items required by the pGLO kit):
o Electrocompetent cells
o 100 mM Stocks of the UAAs to be used
o For 100 mM pIF dissolve 29 mgs of pIF into 1 mL of deionized water
o For 100 mM pAcF dissolve 21 mgs of pAcF into 1 mL of deionized water
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o For 100 mM pBiPhF dissolve 24 mgs of pBiPhF into 1 mL of deionized
water
o For 100 mM pAzF dissolve 21 mgs of pAzF into 1 mL of deionized water
§

NB: sometimes the UAAs have issues going into solution. As such,
we found it useful to both sonicate the UAAs as well as adding
approximately 5 µL increments of a 10 M NaOH solution to the
UAA (prior to bringing to full volume).

o Pure plasmid stocks of PET-GFPTAG66 and pEVOL-pCNFaaRS
o Prepare IPTG (200mg/mL)
1. Dissolve 2g IPTG (Isopropylthio-B-D-galactoside) in 8 mL of water.
2. Adjust final volume to 10 mL with more H2O if needed.
3. Transfer mixture to 12 mL syringe with filter attached to end.
4. Filter 1 mL aliquots into epis.
5. Store in freezer.
o Prepare 20% (w/v) Arabinose
o Amp/Chlor supplemented agar plates for selection of cells cotransformed with
GFP66+pCNFaaRS
o Expression cultures of cells (at an OD600 ~ 0.7) already harboring plasmids for
GFP66 and pCNFaaRS
o Thus you will already need to have done the cotransformation yourself,
plated these transformed cells on Amp/Chlor agar, selected an isolated
colony for starter culture growth, and begin the expression cultures ~ 2hr
prior to the start of lab.
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Week 2 – Purification of GFP by column chromatography and fluorescence
measurements.
To prepare (beyond the items required by the pGLO kit):
o GFPwt expression cultures must be prepared prior (according to direction in the
pGLO kit) one day before the lab meets.
Common student pitfalls While electroporation is, for the most part, a fairly easy
technique, the risk of “sparking” cells is high for the beginner. As such, we found it
useful to have a more experienced person demonstrate a proper electroporation, and then
had students attempt their own. However, because “sparking” is often common with
beginners, we did not have students redo their transformations if their cells sparked.
Instead, because we were already providing the students with a pre-transformed
expression culture, we reasoned it was not necessary for all students to have successful
transformations. Indeed, the pGLO kit transformants would provide the students with
transformed cells that could then serve as a discussion point for selection methods.
We found that the pGLO kit did not always yield successfully transformed colonies for
all students. As such, we prepared our own expressions of GFPwt (using a PET-GFPwt
plasmid and electroporation) and pelleted the cells prior to start of lab on week 2. Then, if
any students did not have good colonies, and hence GFP expression, they could use the
pelleted-GFP expressing cells we had already prepared for them.

References
(1) Young, T. S.; Schultz, P. G. Beyond the canonical 20 amino acids: Expanding the
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Part II: Editing GFP Fluorescence using the Biological Glaser-Hay

Protein engineering is a powerful tool for the development of new therapeutics,
catalysts, and biosensors.1 While many advances in the field have been made, designing
novel protein functionality is still a challenge, as it requires an intricate understanding of
the subtle interplay between protein structure and function. Current engineering

113

techniques often focus on using selection and screens to optimize or enhance existing
protein functionality.1 While this method has proved useful for optimizing existing
function, generating new function where it does not exist is still a hurdle.
Unnatural amino acids (UAAs) represent a unique means to introduce new chemical
functionality into proteins. Using the Schultz methodology, UAAs are co-translationally
incorporated into a protein’s primary sequence, typically in response to a stop codon
introduced at the DNA level.2,3 As such, UAA mutagenesis allows for the site-specific
incorporation of a novel chemical functionality into proteins, which can then be exploited
towards the development of novel protein activities. By inserting new chemical reactivity
into a protein, UAAs allow for a condensed and facile workflow for engineering new
protein functionality without the need to perform tedious and lengthy selections and
screens. For example, recent reports from our group and others have site-specifically
incorporated fluorescent UAAs into proteins, yielding novel fluorescent properties in a
protein in a direct and highly controlled fashion.4,5
While UAAs have allowed for the development of unique protein function, the evolved
protein are often limited to a single new function, depending on the UAA incorporated.1
In addition, the functionality is limited to the UAA itself, which suffers from constraints
such as the requisite for an aminoacyl tRNA synthetase capable of recognizing the UAA,
the synthetic accessibility of the UAA, and the size of the UAA which may preclude its
uptake by a biological system.1–3,6 A more appealing strategy would allow for the
generation of a UAA-containing protein “template” upon which researchers could
synthetically introduce different chemical moieties that would in turn lead to altered
protein function depending on the moiety employed.
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Bioorthogonal chemistry, which employs reactions that proceed to completion under
physiological conditions (pH ~7, 37°C), offers a unique mechanism to add new chemical
functionality to proteins.6,7 Indeed, a variety of reactions have been developed that can
add new chemistry to living systems. In particular, the cycloaddition between azides and
alkynes that is either copper(I) mediated or strain promoted, has become a widespread
technique to introduce new chemistry to proteins. More recently, our group has
developed a biorthogonal variant of the Glaser-Hay reaction, which brings together two
terminal alkynes to form a diyne on a protein in the presence of copper(I) under
physiological conditions.8 The resulting stable diyne linkage has a well-defined
conjugated linear geometry, and due to the abundance of commercial available terminal
alkynes, a variety of chemical moieties can be reacted onto a protein using this technique.
As such, our group sought to use the power of this new chemistry to generate new and
different protein function dependent upon the alkyne reaction partner and not purely the
UAA.
Specifically, we designed a proof-of-concept experiment to alter the function of green
fluorescent protein (GFP) via reaction of different terminal alkynes, onto the GFP
chromaphore. GFP is a 27kDa protein isolated from Aequorea victoria with novel
photochemical properties arising from an internal chromophore composed of Ser65Tyr66-Gly67.9 New chemical properties afforded simply by UAA introduction in place of
Tyr66 have already been documented to alter GFPs fluorescence profile. All UAAs
incorporated were found to blueshift the fluorescence profile of GFP, with more highly
conjugated UAAs exhibiting a greater degree of blueshifting.5 Based on these results, the
ability to modulate the conjugation of GFPs fluorophore using UAA mutagenesis is
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apparent, and represents a convenient means to rationally design new protein function.
However, this mutagenesis approach is limited by the size and complexity of the UAA. A
potentially better approach involves exploiting the chemical functionality in preexisting
UAAs to serve as a handle for biorthogonal reactions, acting as a “template” for the
chemical derivatization of new protein function.
This chemically directed protein evolution could be achieved via the genetic
incorporation of p-propargyloxyphenyalanine (pPrF, 1) or p-ethynylphenylalanine (pEtF,
2) into residue 66 of GFP (Figure 5). This provides a terminal alkyne reaction handle for
reaction with different chemical moieties via the biorthogonal Glaser-Hay reaction. The
resulting diyne linkage is highly conjugated, and a prime candidate to introduce larger
conjugation patterns into GFP’s fluorophore without the need to evolve a new aaRS or
use large UAAs. Moreover, the pEtF (2) is directly conjugated with the aromatic ring of
the UAA, allowing for a comparison of the conjugation between the different UAAs. We
hypothesized that the altered conjugation and chemical properties around the fluorophore
will lead to new photophysical properties, demonstrating the utility of terminal alkyne
containing UAAs and biorthogonal chemistry in a chemically programmable protein
engineering strategy. Herein we report our findings on utilizing the Glaser-Hay reaction
on GFP’s fluorophore to introduce novel function.
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Figure 32. Modification of GFP function via UAA mutagenesis. A) GFP Β-barrel (green) with the chromophore (red) and
chromophore structure. B) Unnatural amino acids employed as bioconjguation handles.

In order to obtain protein possessing an alkynyl moiety, a GFP plasmid harboring a
TAG mutation at position 66 was co-transformed with the polyspecfic pCNF-aaRS/tRNA
pair. Conveniently, this aaRS is capable of recognizing both 1 and 2 and for expression of
an alkyne-containing GFP.5 As the alkynyl UAA is incorporated into position 66 in
GFP’s fluorophore, the extended conjugation afforded by the UAA alters the spectral
properties of GFP. To assess that pPrF-GFPTAG66 was successfully produced, spectra for
the GFP-variant were compared to the wild type. These spectra exhibited blue-shift, in
agreement with the literature precedent, in the pPrF variant relative to the wild type.
Incorporation was also confirmed by SDS-PAGE analysis of protein expression in the
presence and absence of the UAA. A similar expression was performed using the pCNF
aaRS/tRNA pair and pEtF to produce a separate GFP mutant with a bioconjugation
handle. Conveniently, due to the modularity of this approach, only a single protein
expression is necessary and all functional modification can be achieved synthetically.
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This is in contrast to previous experiments, which required an individual protein
expression for each UAA in order to modify function.
With a pPrF-GFPTAG66 and pEtF-GFPTAG66 in hand, we then sought to use our
previously reported biorthogonal Glaser-Hay reaction to install new and varied chemical
functionality into the chromaphore of GFP (Figure 2). To investigate, we performed
biorthogonal Glaser-Hay reactions on the chromaphore’s alkyne handle to couple
aliphatic, aromatic, and alcohol containing alkynes. Briefly, Glaser-Hay reactions were
performed by using a working concentration of 500 mM of CuI and TMEDA in the
presence of alkyne-UAA bearing GFPTAG66 and the cognate alkynyl partner (scheme 1).
Reactions were run for 4 hr at 4°C and then 10 µL of the reacted GFP was placed in 3 mL
of phosphate-buffered saline solution (pH ~7.2) for analysis using fluorescence
spectroscopy. Gratifyingly, our initial attempts with aliphatic terminal alkynes worked
well. Furthermore, the different characteristics of the alkyne moieties installed
successfully shifted the fluorescence profile away from the parent alkynyl-GFPTAG66
spectra, each in a unique way. While it might be expected that the requisite for the
reaction to occur within the β-barrel of GFP may hinder this reaction from occurring, we
hypothesize that the hydrophobic nature of interior of GFP actually promotes the soluble
alkyne localization, thereby facilitating the reaction by increasing effective concentration.
Additionally, SDS-PAGE analysis with Coomassie revealed that the Glaser-Hay reaction
only minimally altered protein concentration suggesting only minimal protein
degradation.
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We found that our initial Glaser-Hays on pPrF-GFPTAG66 had different effects on the
fluorescent profile of GFP (Figure 7A). Reacting 1-hexyne on the chromaphore caused a
general broadening and quasi-red shift of the fluorescent spectra. Reacting propragyl
amine on the chromaphore caused a slight band broadening, as well as potential increase
in fluorescence intensity, likely due to the additional resonance available on the
chromaphore thanks to the lone pair on the amine group.
We next sought to explore the effects of reacting directly onto the phenyl ring of
residue 66. This was feasible with the GFP mutant harboring 2. Interestingly, the direct
attachment of a terminal alkyne onto the ring resulted in an even greater blue shift of the
pEtF-GFPTAG66 compared to the both the pPrF and wild-type variants, likely due to the
increased conjugation due to the direct attachment of that terminal alkyne (Figure 7B).
Because of this shift, a different excitation wavelength was necessary, as 395nm was
found to not excite the pEtF-containing chromaphore. Based on absorption experiments,
we selected 280 nm as the wavelength to excite the pEtF-GFPTag66 and all its Glaser-Hay
derivatives. In the same fashion as the pPrF, the biorthogonal Glaser-Hay was performed
on pEtF-GFPTAG66 using the same reaction partners. Once again, the 1-hexyne was found
to broaden the fluorescence spectra. Interestingly, the propargyl amine reaction had a
drastic red shift relative to the pEtF parent chromaphore. We believe this helps validate
our initial speculation that resonance thanks to the lone pair on the amine has a drastic
impact on the fluorescent properties of the chromaphore, as in this instance the whole
system is in direct conjugated.
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Figure 34. Fluorescent profile obtained after reacting various alkyne containing partners with pPrf or pEtF-containing
GFPTAG66. A) Fluorescent spectra for Glaser-Hay modified pPrF-GFP chromaphore. B) Fluorescent spectra for Glaser-Hay
modified pEtF-GFP chromaphore.
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We have attempted Glaser-Hays with aromatic conjugation partners using the same
reaction conditions as above. However, it was found that the signals obtained following
these reactions were just for the free aromatic partner floating in solution. As such, we
cleaned and concentrated these reactions using a 10 kDa molecular weight cut off spin
column to remove any unreacted aromatic group for a test reaction between pEtFGFPTAG66 and 4-ethynylanisole. The data is still inconclusive, as the spectra does not
appear to have shifted relative to the the parent pEtF chromaphore (Figure 7B). We are
worried that the aromatic alkynes may be shielded by solvent, perhaps preventing these
alkynes from entering the hydrophobic region within GFP’s Β-barrel. We are continuing
to attempt these Glaser-Hay couplings, and will be attempting a different reaction
protocol with a greater concentration of protein to see if this enhances our yields, and
thus signal, of the aromatic derivatized GFP chromaphores.

Conclusion
We have extended our work on the biological Glaser-Hay to utilize the
biorthogonal chemistry to modulate protein function. Using two previously reported
alkyne-containing UAAs within the chromaphore of GFP (position 66), we have
successfully performed the Glaser-Hay reaction on the chromaphore of GFP. The
resulting diyne linkage alters the fluorescence profile of GFP depending on the moiety
attached to the terminal alkyne. Our future work seeks to extend the reaction to aromatic
containing alkynes, which we hope will have a greater impact on GFP fluorescence due
to the increased conjugation found in an aromatic system. Our findings highlight the
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potential of biorthogonal chemistry, particularly diyne forming chemistries, to modulate
protein function without the need for tedious selections and screens.

Experimental
General Biological Glaser-Hay Protocol To 1.5 mL Eppendorf tube was added 3 µL of a
500 mM CuI solution in water and 3 µL 500 mM TMEDA solution in water. This
mixture was then allowed to sit in the fridge for 10 mins. After waiting, 22 µL of PBS
was added, followed by 10 µL of the alkyne containing GFPTAG66 in PBS (~0.5mg/mL)
and 4 µL of a 40 mM solution of the cognate alkyne in DMSO. The mixture was allowed
to react at 4°C for 4 hr.
Protocol for Fluorimetry Scans After reacting for 4 hr, 10 µL of the reaction mixture was
added to a quartz cuvette and diluted up to 3 mL with PBS. This was then excited at
either 395 nm (for the pPrF-containing chromaphore) or 280 nm (for the pEtF-containing
chromaphore) with a 10 nm slit width for the excitation and emission wavelengths. Slit
widths were increased or decreased as necessary depending on the intensity of the
reaction product’s signal. The scan speed was set at 500 nm/min.
General Protocol for Biological Glaser-Hay with Aromatic Reaction Partners To 1.5 mL
Eppendorf tube was added 3 µL of a 500 mM CuI solution in water and 3 µL 500 mM
TMEDA solution in water. This mixture was then allowed to sit in the fridge for 10 mins.
After waiting, 22 µL of PBS was added, followed by 10 µL of the alkyne containing
GFPTAG66 in PBS (~0.5mg/mL) and 4 µL of a 40 mM solution of the cognate alkyne in
DMSO. The mixture was allowed to react at 4°C for 4 hr. Following this, the unreacted
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aromatic alkyne was washed away using a 10 MWCO spin column (Corning) and rinsing
with 50 µL portions of PBS 8 times. After the eight rinse, the solution was concentrated
down to ~25 µL, as indicated on the spin column. Of this cleaned solution, 10 µL was
placed into a quartz cuvette and diluted to 2 mL with PBS for fluorescence analysis.
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CHAPTER 5: IMMOBILIZATION OF THE RNA-GUIDED ENGINEERED
NUCLEASE CAS9

RNA-guided engineered nucleases (RGEN) represent a novel form of targeted
gene editing tools. In these systems, an RNA molecule provides targeting specificity to a
protein endonuclease via RNA:DNA complementarity1,2. Synthetic oligonucleotides are
commercially available, and the ease with which these systems can be programmed to cut
DNA has allowed for rapid developments in the field of molecular biology. The facility
with which DNA editing can be programmed has allowed for rapid new developments in
transgenic models that were previously tedious or inaccessible due to embryonic lethality.
For example, a recent technique employs Cas9 deleting adult-cardiac specific genes,
developing new adult mouse models for cardiac disease that were previously inaccessible
due to embryonic lethality.3 In addition, the ability to selectively excise portions of DNA
has made the technology an attractive new therapeutic. A recent report in Nature:
Scientific Reports detailed the use of CRISPR/Cas9 to remove latenetly infected HIV-1
from T-lymphocytes, effectively providing a cure for HIV/AIDS.4 The clustered regularly
interspaced short palindromic repeats (CRISPR), which act in association with CRISPRassociated (Cas) genes, is a type of RGEN that has gained recent attention as a new tool
for genetic manipulation.
Within the system, the Cas endonuclease, called Cas9, acts in conjunction with a
CRISPR RNA (crRNA), which provides specificity by base pairing with the DNA target,
in effect serving as a bacterial adaptive immunity. When a bacterium survives a viral
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infection, it stores a short segment of the viral genome in the CRISPR region of the
bacterial genome; subsequent infection activates transcription of this short viral segment
which serves as a crRNA, directing the Cas9 nuclease to destroy the viral genome (Figure
1A). In addition to the crRNA, a trans-activating CRISPR RNA (tracrRNA) is required to
allow proper interaction between the crRNA and the DNA (Figure 1A). Recently, the
Cas9 from Streptococcus pyogenes has been made amenable to laboratory use (Figure
1B) 2.
Oligonucleotides can be easily designed and synthesized to facilitate directed
Cas9 targeting of specific DNA sequences in a range of organisms. Furthermore, the ease
with which DNA binding can be programmed with Cas9 is also making the technology
an attractive option as a new biomolecular tool. For example, CRISPR interference
(CRISPRi) has become a valuable new technique for sequence specific gene
transcriptional modulation. By using a catalytically inactive variant of Cas9 (also called a
“dead” or dCas9), researchers were able to sterically hinder transcription of a gene
targeted by a guide RNA.5 The technique has even been extended to transcriptional
activation (CRISPRa) by fusing dCas9 to viral transcriptional activators, such as VP64.6
In this example, the protein serves as a platform for the docking of transcription
activators, and is directed to the gene of interest by the sequence of the guide RNA. Even
more recently, researchers were able to generate a variant of Cas9 containing the ligandbinding domain of human estrogen receptor-α (ER-LBD).7 Upon binding of the
antagonist 4-hydroxytamoxifen, the ER-LBD undergoes a conformational change brining
the N and C termini of the domain closer together, thereby rendering the Cas9 active once
again. This mechanism was shown to serve as an allosteric switch for the exogenous
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control of either Cas9 or dCas9, granting an even greater degree of user-control over
genetic manipulation.
Cas9, therefore, represents a new tool to perform user defined genetic
manipulations. An ideal requisite for genetic manipulation is the propensity of the RGEN
to have maximal on-target cleavage with no off-target cleavage. Given that Cas9 is
directed by RNA:DNA complementarity, and that there are often redundant sequences
within the entire genome or between homologous chromosomes, there is growing
concern that Cas9 mediated cleavage may have off-target effects.8 However, recent highthroughput studies have provided new insight into Cas9 specificity that will lead to
optimal guide RNA design.
Guide RNA mismatch is linked to off-target cleavage
Early studies on the CRISPR/Cas9 system sought to elucidate the role of the
crRNA and tracrRNA in mediating directed DNA cleavage. By using an electrophoretic
mobility shift assay, researchers were able to demonstrate that the constant tracrDNA is
necessary for crRNA binding to target DNA, presumably by helping to orient the crRNA
via formation of a hairpin loop structure. By sequentially truncating the tracrRNA, it was
then possible to determine the minimum tracrRNA sequence required to maintain DNA
cleavage. This was then fused to the last 20 nucleotides of the crRNA 3’ end, which were
shown to provide the system’s specificity to target DNA (see Fig. 1). The resulting
chimeric single guide RNA (sgRNA) produced targeted DNA cleavage at levels
comparable to the naturally occurring system (see Fig. 1) 2.
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Figure 35. (A) Chimeric single guide RNA design mimics critical RNA structures in the crRNA:tracrRNA duplex. The
yellow bar denotes the 20 nucleotide targeting sequence in the sgRNA, which can be programmed by the user.
Presence of the PAM 5’NGG3’ sequence is a restriction on sgRNA design, as only sequences 5’ of the PAM can be
targeted. (B) Chimeric sgRNA+Cas9 cuts a DNA template as efficiently as the crRNA:tracrRNA+Cas9 system. This is
observed via the presence of a cleaved 13 nt sequence after gel electrophoresis. Adapted from Jinek et al., 2012.

In theory, the sgRNA would allow programmed Cas9 cleavage to any DNA target
by base pair complementarity. However, additional studies revealed the requisite of a
protospacer adjacent motif (PAM) on the 3’ end of the target DNA sequence in the form
of 5’-NGG-3’ (see Fig. 1). Even a single mutation in the GG sequence abolishes Cas9
cleavage 2.
While these studies demonstrated programmable Cas9 cleavage, it was still
unclear if there would be any off-target effects that would minimize the specificity and
thus applicability of the enzyme. However, this requires scientific ingenuity, as exploring
every positional mismatch within the sgRNA and the whole genome is incredibly
challenging. Early studies focused on examining mismatches within the sgRNA targeting
sequence towards a target gene. This served as a proxy for off-target cleavage within the
genome. Researchers designed sgRNAs targeting the human hemoglobin β (HBB) gene
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with different mismatches. Using the T7E1 assay (see Fig. 2), the authors demonstrated
that the mismatched sgRNAs could lead to indel formation in the HBB gene, indicating
non-perfect complementarity is permissible for Cas9 cleavage (Cradick et al., 2013).
These findings were corroborated in a functional assay that relied on Cas9 disruption of
GFP via indel formation. Relative to the perfectly matched sgRNA, the authors observed
that the sgRNA tolerated single and double mismatches within the 20 nucleotide
specificity sequence, especially if they were in the 5’ end most distal from the PAM 8.
Current findings reveal less promiscuity in cleavage
Unlike previous studies, researchers generated guide RNAs with single and
double mismatches at every position and combination in the RNA’s 20 nucleotide
targeting sequence using automated oligonucleotide synthesis. Using a functional assay
in which fluorescence serves as a metric for off-target cleavage, the researchers
performed a comprehensive analysis of guide RNA positional mismatch effects. Once
again, their findings revealed that the most PAM distal nucleotides were tolerated for offtarget cleavage. However, upon exploring every possible double mismatch combination,
they found that only sequential double mismatches at this distal site had any real effect on
off-target cleavage (see Fig. 2). Triple mismatches abolished off-target cleavage in this
study. Their data further validate that mismatches between the sgRNA and off-target sites
are only tolerated at the most PAM distal nucleotides within the target sequence.
Furthermore, the authors argued that off-target effects would be minimized by the
requisite combination of favorable mismatches adjacent to a PAM sequence

10

positional data can be employed in the future to design less promiscuous sgRNAs.
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. This

Figure 36. Positional effect of mismatches between the guide RNA and the DNA template as detected via a functional
Ub-GFP assay. Numbers denote position of the mismatch, with 1 corresponding to the nucleotide most distal from the
PAM and 20 corresponding to the nucleotide directly adjacent to the PAM. All GFP values are normalized to the perfect
match levels. (A) As previously observed, nucleotides more distal from the PAM sequence tolerate mismatches more
readily, as observed by an increase in GFP fluorescence. (B) Double mismatches are less permissible than single
mismatches, with a sequential mismatch in nucleotides 1,2 tolerated the most. The inset demonstrates all possible
combinations of double mismatches within the guide RNA, demonstrating that vast majority of double mismatches are
not tolerated. Adapted from Anderson et al., 2015.

These authors’ conclusions were further validated by a powerful new assay
capable of capturing Cas9 off-target cleavage sites within the entire genome. This
technique, termed Digenome-seq, allowed the authors to probe the entire genome for offtarget cleavage of a sgRNA targeting the HBB gene. Using Digenome-seq, the authors
were able to capture the on-target site as well as two previously validated off-target sites.
Another 122 other potential off-target sites were also captured. However, whole genome
sequencing (WGS) of Cas9 transfected cells revealed that these 122 other sites were not
accompanied by indels, suggesting that mutations at these off-target sites are rare. Based
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on their findings, off-target cleavage would not be expected to exert an effect on the cell
11

. In comparison to previous techniques, this method was the first to allow researchers to

probe the genome for off-target sites of a sgRNA they wish to employ in the future.
Recently, the Doudna group revealed insight into the mechanism of Cas9:DNA
binding that negates off target cleavage. By using Forster resonance energy transfer
(FRET) experiments to explore conformational changes in Cas9 upon binding DNA, the
group revealed that Cas9 adopts a unique conformation with perfect sgRNA:DNA
complementarity (see Fig. 3). Mismatches, even in the distal portion of the sgRNA
targeting sequence, have distinct conformations that presumably disfavor enzymatic
cleavage. This provides structural evidence for a conformation-dependent proofreading
mechanism for Cas9 based on the complementarity of the sgRNA and the DNA. As such,
it is thought that this proofreading mechanism helps minimize off-target cleavage
(Sternberg et al, 2015).

Figure 37. FRET experiments involve attaching two fluorophores to a protein. As the protein undergoes conformational
changes, the distance between the fluorophores changes. This alters their fluorescence intensity which serves as a
metric for structural changes within the protein. FRET data from the Doudna group demonstrates a conformational
control of DNA target cleavage in Cas9. In comparison to the perfect complementarity between the sgRNA and the
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target DNA (on-target), mismatches demonstrate a different degree of conformational change (y-axis). Adapted from
Sternberg et al., 2015.

DNA-Fishing using Cas9
The ease with which Cas9 can be programmed to target certain genetic loci has
made it an increasingly attractive tool, especially towards molecular genetics. Recent
work has established a methodology to use an inactive form of Cas9 (“dead” or dCas9),
which can still bind specified DNA sequences using a gRNA, to pulldown specific
genetic loci. These loci are pulled down with their associated proteins, allowing
researchers to efficiently isolate certain genetic regions and their associated proteins,
expanding our limited understanding of the varied roles proteins play in regulating
expression.13 The technique, termed engineered DNA-binding molecule-mediated
chromatin immunoprecipitation (enCHIP), was applied to the human interferon (IFN)
regulatory factor-1 (hIRF-1) and was demonstrated to pull down new and validated
protein targets.14 While the technique works and exhibits minimal off-target effects, it
requires binding of the dCas9 complex to the DNA in vivo, perhaps precluding certain
protein factors that may interact at that region or altering the favorability for other
regulators to bind.
Due to the increasing widespread applicability in a variety of molecular biology
endeavours, we sought to develop a UAA-containing Cas9. Our hope was that by
incorporating UAAs into Cas9, we could generate either a photoactivatable Cas9, using
photocaged UAAs, or immobilize Cas9 onto a solid support for DNA-pulldown
applications. It is our hope that the by installing new biochemistries into Cas9 via UAAs
that will further increase the applicability of this technology for a more diverse array of
applications.
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Results and Discussion
Our group has already established a protein immobilization protocol using UAA
technologies. Immobilization of Cas9 on a bead may allow specific targeting of certain
genetic loci, producing a more complete picture of the role of protein function in
regulating DNA, as well as affording a new means to purify genetic material of interest.
Cas9 immobilization to a resin or bead may also allow for the regeneration of the system,
allowing researchers to purify defined DNA sequences multiple times.
Initially, sites within the amino acid sequence of the Cas9 enzyme that would
amenable to UAA-mutagenesis were identified. As a consequence of most bacterial
aaRSs having been evolved for tyrosine derivatives, we relegated our investigation to
tyrosine residues within the protein. In addition, the search was further constrained by the
necessity to utilize a surface exposed tyrosine residue that did not perturb canonical Cas9
DNA cleavage. It was our hope that this exposed residue could serve as a handle for
biorthogonal functionalization.
Our initial search identified Tyr1265 as a prime candidate for immobilization, as
it is distal to Cas9’s catalytic domains and is surface exposed (see Fig 4). Our choice was
further validated by a recent study that sought to identify engineering hotspots within
Cas9.7 It was found that amino acid residues in the CTD of Cas9 were particularly
amenable to alteration without drastically impairing protein function. While Y1265 was
not directly explored, residues 1262 and 1267 were, and they both continued to exhibit
functionality, albeit a bit decreased. Moreover, because the screen was performed by
insertion of a large protein domain, we hypothesize that the small size of the UAA
insertion will have a minimal effect on Cas9 function.
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Tyr1265

Figure 38. Cas9 with HNH (magenta) and RuVCIII (cyan) highlighted. Proposed site of UAA mutagenesis (Y1265) is
shown in red.

Having selected Tyr1265 as the ideal site for UAA incorporation, we then
designed primers for PCR mutagenesis, converting Y1265 into a TAG for UAA-mediated
amber suppression. PCR mutagenesis using Kappa Hi-Fidelity polymerase was
performed according to the Kappa protocol. Subsequent sequencing and alignment of the
plasmid obtained from this mutagenesis showed that we had indeed inserted a TAG into
position 1265, generating a Cas9Y1265X variant.
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Site of mutagenesis

Original DNA sequence with nt position (5’-3’)
Forward primer (3’-5’)
Reverse primer (5’-3’)
Original AA sequence with AA position
Original DNA sequence (5’-3’)

New complementary DNA sequence (3’-5’)
Figure 39. Results from sequencing and alignment for our PCR mutagenesis. Flow chromatogram on the bottom
highlights in the red the incorporation of our TAG mutation on the complementary DNA sequence (3’-5’).

Following insertion of the TAG mutation, it was then necessary to optimize our
expression protocol. Cas9 is an approximately 160kDa protein, and thus expression
represents a serious energetic toll for the cell. Combining the expression of this large
protein with the added layer of UAA incorporation increases the complexity of the
process. To optimize UAA incorporation into Cas9Y1265X we performed an expression
experiment with the pET-Cas9Y1265X and the pEVOL-WT plasmids. pEVOL-WT is the
wild type aaRS from M. jannaschii, and will charge tyrosine to the cognate tRNA with an
antisense codon for the TAG stop codon. Thus, after this process the protein produced is
the wild type Cas9, but amber suppression is required. This method, therefore, serves as a
good proxy for our capability to incorporate a UAA without the added complexity of a
UAA in the system.
To optimize Cas9Y1265X expression, we performed expression experiments
using 100mL expression cultures of E. coli BL21(DE3). These cultures were either
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grown in Luria-Burtani (LB) broth or 2x Yeast tryptone (2XYT), a more nutritionally
rich broth that is often advantageous for the expression of large proteins. In addition, we
also explored the effects of concentration our expression cultures prior to induction, as
our previous work with GFP has shown that a 5x concentration enhances protein yields
while minimizing the amount of UAA required.
Our results from the expression experiment show that we were indeed able to
generate wild type Cas9 using the amber suppression method. To our surprise, the 1x LB
expression protocol performed best. We hypothesize that the large demands imposed by
the expression of such a large protein makes our concentration protocol very demanding
on the cell, as it now finds itself in a nutritionally diminished environment while
expressing Cas9. In addition, the 2XYT expressions did not outcompete the 1x LB
version, perhaps because the increased nutritional supplies of the 2XYT broth allowed
the cells to focus energetic resources towards continued growth and division instead of
increasing cellular size and protein expression.
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Figure 40. Protein expression experiment for pET-Cas9Y1265X and pEVOL-WT. Our data indicates that the 1x LB
protocol performs best, as evidenced by denatured SDS-PAGE following staining. FT in the figure refers to flowthrough, which demonstrates that we have captured all the Cas9 produced by the cells.

With an optimized expression protocol for the incorporation of a UAA into
Cas9Y1265X, we next sought to produce a UAA-containing Cas9. A pET-Cas9Y1265X
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was co-transformed with the polyubiquitous pCNF-synthetase. The 1x LB protocol was
then used with 100 mL expression cultures either in the presence or absence of the UAA
pAzF, introducing an azide functionality into the protein. Gratifyingly, our data show that
the UAA is incorporated (see Fig 7, Lanes 3-5) in the presence of UAA. Furthermore, in
the absence of UAA, no protein is produced, as the cell encounters an early stop codon in
protein translation (see Fig 7, lanes 7-9). Furthermore, no truncated protein products can
be detected since our Cas9 contains a C-terminal hexaHis tag, meaning only completely
successful read-throughs produce our purification tag.
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Figure 41. Expression of a pAzF-containing Cas9Y1265X.

Experimental
General Protocol for PCR Mutagenesis PCR mutagenesis was performed in a Bio-Rad
iCycler 96 well reaction module thermocycler. The protocol was adapted from the Kappa
Polymerase HiFi PCR mutagenesis protocol. Two, 1x master mix for the PCR reaction
were created by adding 5 µL Kappa HiFi Buffer, 0.75 µL 10 mM dNTPs, 0.75 µL, 0.75
µL of 10 mM of forward primer dissolved in sterile deionized water, 0.75 µL of 10 mM
of reverse primer also dissolved in sterile deionized water, and 12.25 µL of sterile
deionized water. To the reaction master mix was added 0.5 µL of kappa polymerase at
the very end, prior to starting the reaction in the thermocycler. To the control master mix

137

was added 0.5 µL of sterile deionized water in place of the kappa polymerase. This recipe
for the 1x master mix was increased by 2.5x or 5x depending on the number of reactions
that were being run. For example, for the PCR mutagenesis converting Tyr1265 to
TAG1265, four experimental PCR tubes were prepared, two with 5 ng of pET28b-Cas9His (5 µL of 1ng/µL of template DNA) and two with 10 ng of pET28b-Cas9-His (5 µL of
2ng/µL of template DNA). To these PCR tubes was then added the corresponding
reaction or control master mix, which was then loaded into the thermocycler using the
following protocol: 1) initial denaturation at 95°C for 2 mins; 2) denaturation at 98°C for
2 mins followed by annealing at 65°C or 15 secs [note, 2°C were added to whatever the
IDT reported annealing temperature was because the Kappa HiFi buffer is a high salt
buffer that increases annealing temperatures] followed by an extension at 72°C for 4.5
mins (30 sec/kbp), this step was cycled for a total of 20 cycles; 3) a final extension was
performed at 72°C for 5 mins; 4) the thermocycler completed the run by holding at 4°C.
Following the PCR mutagenesis, the samples then underwent a DpnI digestion at 37°C
for 2 hours to remove any methylated template DNA. The DpnI was deactivated at 80°C
for 15 mins, and the samples were then PCR cleaned and concentrated (Zymo Research
DNA clean and Concentrator Kit) and eluted in 10 µL of sterile deionized water. Two
microliters of each sample were then transformed into competent E. coli (BL21(DE3)),
recovered in 500 µL of 2XYT media for 1 hour, and then this full volume was plated on
agar plates supplemented with kanamycin. After allowing to grow overnight, plates were
compared for differential growth between the reaction and control. If differential growth
was observed, four colonies were picked at random in four different quadrants of the
plate. These were grown to confluence overnight at 37°C, a glycerol stock was prepared
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using 1 mL of culture, while the rest was used to extract DNA for sequencing and
expression tests.
Primers Designed for PCR Mutagenesis of pET28b-Cas9-His
Primer ID

A9
A10
A11
A12
A13
A14
A15
A16
A17
A18

Mutation

D10TAG_F
D10TAG_R
Y72TAG_F
Y72TAG_R
Y450TAG_F
Y450TAG_R
Y1131TAG_F
Y1131TAG_R
Y1265TAG_F
Y1265TAG_R

Explanation

Template Plasmid

to convert Cas9 to dCas9 via inactivation of catalytic D(restor with YOBNY?) pET28b-Cas9-His
pET28b-Cas9-His
Tyr interacting with DNA base (pi-pi stacking)
pET28b-Cas9-His
pET28b-Cas9-His
Tyr inactivated in dCas9??
pET28b-Cas9-His
pET28b-Cas9-His
Tyr near DNA
pET28b-Cas9-His
pET28b-Cas9-His
Tyr surface exposed and away from DNA/HNH and RuvC catalytic domains pET28b-Cas9-His
pET28b-Cas9-His

IDT Calculated Tm Verified Tm

67.3
67.3
68.0
68.0
64.5
64.5
66.2
66.2
63.2
63.2

Sequence

aagtactccattgggctctagatcggcacaaacagcgtc
gacgctgtttgtgccgatctagagcccaatggagtactt
68.0gaacagcacggcgcagatagacccgcagaa
68.0gaacagcacggcgcagatagacccgcagaa
catttcggataccctagtatgtaggccccctcg
cgagggggcctacatactagggtatccgaaatg
68.2agattgggaccccaagaaatagggcggattcga
68.2tcgaatccgccctatttcttggggtcccaatct
65.0ACACAAACACTAGCTTGATGAGATCATCGAGCAAATAAGC
65.0GCTTATTTGCTCGATGATCTCATCAAGCTAGTGTTTGTGT

Sequencing of PCR Mutagens
Samples were sent off to sequencing to GeneWiz using their “premixed” DNA
Sequencing Services following their sample submission guidelines. For the Cas9Y1265X
mutagen the universal T7 terminator primer was selected for sequencing. This primer will
be utilized to sequence Cas9Y1131X as well. For mutagens Cas9D10X and Cas9Y450X
the universal T7 promoter primer will be used for sequencing. The Cas9Y450X mutant is
located too far into the DNA sequence of the Cas9 gene for reliable sequencing using
either of the universal primers above, as such we will design a sequencing primer nearer
to this mutation site.
Optimization Cas9TAG Cotranslational UAA Incorporation A pET-Cas9Y1265X
plasmid (0.5 µL) was co-transformed with a pEVOL-WT plasmid (0.5 µL) into
Escherichia coli BL21(DE3) cells using an Eppendorfeporator. The cells were then plated
and grown on LB agar in the presence of chloramphenicol (34 mg/mL) and kanamycin
(50 mg/mL) at 37 ̊ C overnight. One colony was then used to inoculate LB media (5 mL)
containing both kanamycin and chloramphenicol. The culture was incubated at 37 ̊ C
overnight and used to inoculate an expression culture. Expression cultures were either
grown in LB media (100 mL 50 mg/mL Kan, 34 mg/mL Chlr) or 2XYT media (100 mL
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50 mg/mL Kan, 34 mg/mL Chlr) at an OD600 0.1. The cultures were incubated at 37 ̊ C
to an OD600 between 0.6 and 0.8. Protein expression was either induced immediately via
addition 20 % arabinose (100 µL) and 0.8 mM isopropyl β-D-1-thiogalactopyranoside
(IPTG; 100 µL) or the cultures were concentrated 5x to a volume of 20 mL and expressed
via addition of 20% arabinose (20 µL) and IPTG (20 µL). The cultures were incubated at
room temperature for 24 h then centrifuged at 5,000 rpm for 20 minutes, as the larger
expression cultures required longer centrifuge times to ensure all the cells were pelleted.
The pelleted cells were then stored at -80 ̊ C for 20 mins. The cell pellet was resuspended
using 500 µL of Bugbuster (Novagen) containing lysozyme, and incubated at room for 30
minutes. The solution was then centrifuged at 5,000 rpm for 20 mins. The supernatant
was added to an equilibrated His- pur Ni-NTA spin (Qiagen) column and Cas9 was
purified according to manufacturer’s protocol. Purified GFP was analyzed by SDS-PAGE
(BioRad 6% precast gels, 150V, 1.5h), and employed without further purification.
Expression of UAA-Containing Cas9Y1265X A pET28b-Cas9Y1265X-His plasmid (0.5
µL) was co-transformed with a pEVOL-pCNF plasmid (0.5 µL) into Escherichia coli
BL21(DE3) cells using an Eppendorf eporator. The cells were then plated and grown on
LB agar in the presence of chloramphenicol (34 mg/mL) and kanamycin (50 mg/mL) at
37 ̊ C overnight. One colony was then used to inoculate LB media (10 mL) containing
both kanamycin and chloramphenicol. The culture was incubated at 37 ̊ C overnight and
used to inoculate an expression culture (100 mL LB media, 50 mg/mL Kan, 34 mg/mL
Chlr) at an OD600 0.1. The cultures were incubated at 37 ̊ C to an OD600 between 0.6
and 0.8, and protein expression was induced by addition of UAA (1 mL, 100 mM) and 20
% arabinose (100 µL) and 0.8 mM isopropyl β-D-1-thiogalactopyranoside (IPTG; 100
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µL). The cultures were incubated at room temperature for 16-20 h then centrifuged at
5,000 rpm for 10 minutes and stored at -80 ̊ C. Purification was performed according to
the protocol above using a Ni-NTA resin.
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CHAPTER 6: TOWARDS THE DEVELOMPENT OF GLASER-HAY “TURNON” PROBES

In order for a fluorescent probe to prove beneficial, it must possess certain key
features. The first constraint is size, as the probe must be small enough to enter the cell,
yet large enough to provide enough information for specificity and a prolonged signal.1
Additionally, the signal must occur selectively where the probe is meant to bind, with
minimal interfering background.1 Most importantly, the fluorescent probe must bind
exclusively to the substrate of interest.1
Turn-on fluorescent dyes, or profluorophores, represent a unique means of
developing chemical probes. These probes are chemically designed to produce a signal
after undergoing a particular reaction, which is dictated via the installation of a unique
handle onto the dye (Scheme 1).2,3 These types of probes have gained increased attention,
as they produce low background signal in the absence of their cognate partner, improving
overall signal-to-noise ratios. Furthermore, their cognate partner can be readily installed
into certain regions of the cells (via UAA mutagenesis, for example), allowing the
scientist to better control the localization of their fluorescent signal.
Scheme 10

Profluorophore

+
Cognate partner

Reaction induced fluorescence
turn-on
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Based on the fluorescent imaging advantages intrinsic to profluorophores, we
proposed a strategy that utilizes UAAs, in conjunction with biorthogonal chemistry, to
selectively bind profluorophores to genetically modified proteins that were previously
described to incorporate UAAs. Such an approach allows for the generation of sitespecificity within the reaction of the protein and the label. This affords a high level of
control over the process, and the prevention of protein inactivation and loss of function.
Additionally, this strategy eliminates the background signal, as fluorescence cannot be
observed unless conjugation has occurred. Finally, the literature contains a myriad of
profluorophores that have already been synthesized and can be employed. This permits
for the discovery of dyes of the correct size to provide in vivo diffusion, as well as
different excitation spectra that can be used for simultaneous labeling of multiple proteins
within a single organism.
The unique functional handles that UAAs can introduce into proteins offer a
means to tackle these complexities, as well as reduces the challenges associated with
protein labeling. This strategy is has primarily relied upon upon click chemistry, a
reaction that proceeds to completion readily and in relatively mild conditions.8 Of
particular utility is click chemistry involving azides and alkynes that readily undergo a
Huisgen 1,3-dipolar cycloaddition which produces a stable triazole moiety optimal for in
vivo conjugation.9 Additionally, the scarcity of azides and alkynes in biologic systems
makes these two functional groups optimal for use in developing a click chemistry
strategy of fluorescent labeling, as the chance of cross-reactions are minimal. Moreover,
research has identified profluorphores, or “turn-on” probes, that become fluorescent only
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after a successful click reaction has formed the triazole moiety. Indeed, there are a variety
of click-chemistry compatible turn-on probes in the literature.2–6
Recently, our group expanded the role of terminal alkyne in biorthogonal
chemistry by developing biological variants of the Glaser-Hay and Cadiot-Chodkiewicz
couplings.7,8 Both reactions produce a covalent diyne linkage. The Glaser-Hay reaction
involves the coupling of two terminal alkynes in the presence of copper(I). The CadiotChodkiewicz coupling utilizes a bromoalkyne and a terminal alkyne in the presence of
copper(I) to produce the diyne linkage, adding a degree of chemoselectivity while also
minimizing the requisite amounts of copper(I). In order to further expand the utility of
these chemistries in chemical biology, we sought to explore the potential of these
reactions for “turn-on” probe labeling of proteins via UAAs. We hypothesized that the
added conjugation present in the diyne linkage would mirror that found in the triazole
ring, restoring electron density to the profluorophores and eliciting fluorescence
following successful conjugation.

Results and Discussion
In order to probe the potential of the biorthogonal Glaser-Hay and CadiotChodkiewicz for “turn-on” probe development, we first attempted to synthesize a variety
of terminal-alkyne containing profluorophores. Thankfully, a myriad of such compounds
have already been reported in the literature, possessing a variety of well-defined
fluorophore cores.3,4,6 As such, we sought to synthesize a benzothiazole-, coumarin-, and
xanthenone-alkyne containing profluorophroes.
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Figure 42. Alkyne-containing profluorophores to be synthesized to probe the application of the Glaser-Hay towards
turn-on probes.

The first fluorophore synthesized was ethynylbenzothiazole (1, EBTZ, see
Experimental for synthetic scheme). Starting from 2-aminobenzothiazole, an iodo group
was installed 2-iodobenzothiazole, which could then subsequently undergo a Sonogashira
cross-coupling with trimethylsilylacetylene. Following TMS deprotection using
potassium carbonate in methanol, column chromatography in 6:1 hexanes:ethyl acetate
afforded the 2-ethynylbenzothiazole as a brown solid (7% yield). While the compound
was not initially soluble in the eluent system, a small volume a dichloromethane was used
to help solubilize the reaction mixture for loading onto the silica gel column. Solubility
issues were a major roadblock for the synthesis of all profluorophores, likely due the
highly aromatic nature of many of these fluorophore cores. We hypothesize that tight pistacking between the aromatic rings prevents the solvation of the product. Typically the
addition of a polar solvent, such as dichloromethane or methanol, to the loading solution
as well as sonication of the mixture helped solubilize the bulk of the product for flash
chromatography.
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To verify that the synthesized EBTZ was indeed a profluorophore, a click reaction
was performed using p-azidophenylalanine (pAzF) in water, which mirrored the same
fluorogenic click reaction reported in the literature. The same “turn on” peak as reported
in the literature was observed at ~354nm in the click reaction when excited at 285nm. In
the absence of the copper catalyst system, no real peak was observed, and in the presence
of solely CuSO4, a different peak at ~430nm was observed, likely due to turn on of the
fluorophore as it bound the copper salt. Furthermore, unlike the literature, our fluorogenic
click reaction was run in the presence of the nitrogenous ligand TBTA, which is reported
to drastically increase the rate of the copper(I)-catalyzed cycloaddition of azides and
alkynes. As such, based on the fluorimetery data it appears that our reaction reached
completion within 4 hr, unlike the literature which required ~24 hr to achieve maximum
signal.
A.

O

pAzF

H 3N

OH

O
H 3N
S

CuSO4/TCEP/TBTA
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510

Taken together, the above data verified that the synthesized molecule was indeed
an alkyne-bearing profluorophore. As such, we next sought to investigate whether our
recently developed biological Glaser-Hay reaction could also produce a turn-on response
in the probe. We hypothesized that the added electron density found in the Glaser-Hay’s
diyne linkage would mimic that found in the copper click’s triazole ring, serving to
promote the relaxation of excited state electrons through fluorescence.
To begin, we performed an organic Glaser-Hay with EBTZ in the presence of
propargyl alcohol and phenylacetylene, which mimicked the functional groups found in
our

alkyne-bearing

UAAs

(p-propargyloxyphenylalanine,

pPrF,

and

p-

ethynylphenylalanine, pEtF). Absorption spectra taken on the UV-Vis revealed an
absorption maxima at ~328 nm for the Glaser-Hay between phenylacetylene and EBTZ,
with no real absorption peaks found for the reaction with propargyl alcohol. As such, this
wavelength was chosen to excite the alkyne-bearing UAAs conjugated to EBTZ.
Interestingly, the Glaser-Hay control reaction, in the absence of the copper
catalyst system, with the pEtF had a higher fluorescence response than the Glaser-Hay
reaction between pEtF and EBTZ, with a maximum emission at ~420nm, which
corresponded to the same emission profile of the free pEtF in water. These results were
contradictory to what we expected, as we thought directly conjugating EBTZ to an
aromatic ring would increase fluorescence response. As such, it appears that the aromatic
variant of the Glaser-Hay onto the EBTZ profluorophore serves to quench the
fluorescence intrinsic to the aromatic UAA. There was no fluorescence changed observed
for the reaction between pPrF and EBTZ.
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We attempted the biological Glaser-Hay reaction in a protein context using ppropargyloxyphenylalanine-GFPTAG151 in the presence of EBTZ. However, our results
were inconclusive, as even after extended denaturation the GFP signal swamped our
fluorescence spectra. Future work will attempt the Glaser-Hay using a ppropargyloxyphenylalanine-UbiquitinTAG47, which is a non-fluorescent small protein that
will not convolute our fluorescence spectra with its own fluorescent signal.
In order to verify the potential of the Glaser-Hay reaction to either quench UAAs
or profluorophores, we sought to synthesize other UAAs to help corroborate our initial
findings with EBTZ. These syntheses are ongoing, with varying degrees of success.
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The next profluorphore we attempted to synthesize from the literature was a 3methoxy-6-ethynyl-9H-xanthen-9-one, which possesses a xanthenone core.5 To begin,
2,2’,4,4’-tetrahydroxybenzophenone

was

subjected

to

a

microwave-mediated

condensation reaction in the presence of 10% NaOH to afford 3,6-dihydroxy-9Hxanthen-9-one. This product was then asymmetrically methylated using methyl iodide in
a biphasic solvent system of toluene and 50% NaOH. Unfortunately, we were never able
to isolate the asymmetrically methylated product, largely due to solubility issues in all
our available organic and aqueous solvents. If we had, we would have installed a triflate
group on the free hydroxyl group, which could then undergo a Sonogashira crosscoupling with trimethylsilylacetylene to yield 3-methoxy-6-(2-(trimethylsilyl)ethynyl)9H-xanthen-9-one. This TMS-protected variant could then be deprotected to afford the
terminal alkyne containing 2.
The last proposed profluorophore moiety we are preparing involve ethynylcontaining coumarin profluorophores.

Conclusion
We have begun the synthesis of a variety of profluorohpores to probe the ability
of the Glaser-Hay to serve as a “turn-on” mechanism for these probes. Our initial studies
appear to reveal an actual “turn-off” effect when utilizing the Glaser-Hay in conjunction
with alkyne bearing profluorohpores.

Experimental
Synthesis of 2-ethynylbenzothiazole (1)3
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Synthesis of 2-iodibenzothiazole (1a) via a. To a flame dried round bottom and stir bar
was added 1.875 g (8.085 mmol) of 2-aminobenzothiazole and 7.5 g of p-toluenesulfonic
acid (39.428 mmol). Meanwhile, a salt solution of 5.25 g of potassium iodide (31.627
mmol) and 1.75 g of sodium nitrite (25.362 mmol) in 7.5 mL of deionized water was
prepared. To the round bottom containing the 2-aminobenzothiazole was added 10 mL of
acetonitrile, and to this was promptly added the salt solution. The mixture was stirred at
0°C for 2 hr and then stirred at room temperature overnight. The next day 175 mL of
deionized water were added to the reaction round bottom, and the pH of the mixture was
adjusted to ~8-9 (as indicated via pH strips) using 1M sodium bicarbonate. A spatula tip
of sodium thiosulfate was added to this, which caused a brownish precipitate to crash out.
Any additional sodium thiosulfate was found to hinder the workup procedure. The whole
mixture was filtered on a Buchner funnel and washed with cold water to give 2.106 g of
1a as a brown powder (8.066 mmol, 99% yield) as confirmed by 1H NMR in CDCl3
according to the literature.
Synthesis of 2-ethynylbenzothiazole (1) via b. & c. To a flame dried round bottom and
stir bar, flushed with argon beforehand, was added 0.870 g of 1a (3.334 mmol). The
round bottom was then capped with a septum and flushed with argon. To this round
bottom was added 7 mL of dry dichloromethane. This solution was degassed using argon
for 20 minutes, and then 942 µL of trimethylsilylacetylene (0.65 g, 6.618 mmol) and 3.3
mL of triethylamine (2.409 g, 23.807 mmol) was added via syringe through the cap,
maintaining the integrity of the argon atmosphere. This mixture was stirred under argon,
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and the septum was briefly opened to add 47 mg of bis(triphenylphosphine)palladium(II)
dichloro (0.067 mmol) and 14 mg of copper(I) iodide (0.074 mmol). The reaction was
then flushed with argon and was allowed to stir at 65°C for 4 hr. After 4 hr, 10 mL of a
brine solution was added to the mixture. The reaction was then extracted with
dichloromethane (10 mL x 3) and this organic layer was back extracted using bring (40
mL x 4). The organic layer was then dried with magnesium sulfate, filtered, and
concentrated in vacuo to afford 0.463g of 2-trimethylsilyl-ethynylbenzothiazole (1b)
(2.000 mmol, 60% yield) as a brown powder. To the round bottom containing 1b was
added a stir bar and 10 mL of methanol to check if this solvent would solubilize the
compound. If it did, an additional 10 mL portion of methanol was added to 1b, if not, an
additional 10 mL of dichloromethane was added instead. To the solution was added 1.244
g of potassium carbonate (9.000 mmol) and the reaction was stirred at room temperature
for 2-3 hrs. Next, the reaction was extracted in a 1:2 volume of dichloromethane to brine
(20 mL of dichloromethane x 3, 40 mL of brine total). The organic layer was then back
extracted one time with 60 mL of brine. The organic layer was then dried with
magnesium sulfate, filtered, and concentrated in vacuo. Initial attempts to purify the
reaction with silica gel chromatography in a MeOH:DCM eluent failed. As such the
reaction mixture was dissolved up in a small volume of DCM and purified via silica gel
chromatography using a 6:1 hexanes:ethyl acetate as the solvent system. Twenty-two mgs
of 2-ethynylbenzothiazole (0.138 mmol, 7% yield) were obtained from the column as a
brown residue that was not fluorescent via TLC. 1H NMR
Synthesis of 3-methoxy-6-ethynyl-9H-xanthen-9-one (2)5
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Synthesis of 3,6-dihydroxy-xanthen-9-one (2a) via a. To a microwave vial containing a
stir bar was added 800 mgs of 2,2’,4,4’-tetrahydroxybenzophenone (3.250 mmol). This
was dissolved in 4 mL of a 10% NaOH solution (w/v), and then subjected to microwave
irradiation in dynamic setting (10 mins at 120°C; microwave protocol on Young Lab
CEM as Profluoro st 1). Next, the reaction was subjected to fixed power setting at 150 W,
with a max temperature of 180°C for twelve pulses. After the twelve pulses, the reaction
was diluted with 4 mL of deionized water and acidified with 6 M HCl to give a white,
viscous gel like substance. This was filtered via Buchner filtration to give 2a as a white to
off-white powder.
Synthesis of 3-hydroxy-6-methoxy-9H-xanthen-9-one (2b) via b. To 1.25g of 2a (5.5
mmol) was added 62.5 mL of toluene, which did not solubilize the material. To this
mixture was added 1.25 g (5.5 mmol) of benzyl triethyl ammonium chloride followed by
375 µL (0.781 g, 5.5 mmol) of methyl iodide. Next, 31 mL of a 50% aqueous NaOH
(w/w) solution was added and the reaction was capped and stirred at 110°C for 6 hr. After
the 6 hr the separate phases were separated via a separatory funnel, and the aqueous layer
was collected. The aqueous layer was then acidified with ~12 mL of 12N HCl, which
produced a color change from cloudy yellow, to clear yellow, to a white/milky precipitate
formed once a pH = 4 was reached. The acidified layer then sat on ice for 2 minutes and
filtered via Buchner filtration. The collected crystals sat overnight and were then
recrystallized in 10 mL of boiling toluene. This gave 725 mgs of an off white product
which we thought may be the asymmetrically methylated 2b.
Synthesis of 6-methoxy-9-oxo-9H-xanthen-3-yl-trifluoromethansulfonate (2c) via c. To a
flame dried round bottom and stir bar was added 0.400g (1.65 mmol) of 2b dissolved in
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20 mL of DCM. To this was added 665 µL of dry pyridine (0.653 g, 8.25 mmol) and the
mixture was cooled over ice to 0°C. Everything was flushed with argon while the
reaction

mixture

cooled.

Then,

using

a

needle

and

syringe,

416

µL

of

trifluoromethanesulfonic anhydride (which may or may not have been anhydrous; 0.698
g, 2.475 mmol) dropwise, to the best of my ability. The temperature was gradually raised
to room temperature and the reaction was stirred for an additional 2 hrs. After the 2 hrs,
15 mL of deionized water was to quench the reaction. This mixture was stirred for an
additional 5 mins, and the organic and aqueous phases were then separated. The organic
layer was washed with a 1N HCl solution in water (15 mL x 2), and it was then washed
once more with a 15 mL portion of deionized water. The organic layer was then dried
with magnesium sulfate (which we now believe may be interacting with our
profluorophores and fluorophores, preventing adequate recovery after this step), filtered,
and concentrated in vacuo. Silica gel chromatography in 3:1 hexanes:ethyl acetate
yielded 5 mgs of something that was a single spot on TLC. We were concerned that the
silica gel may be interacting with the triflate group, binding our product to the column
during the purification process.
Cu(I)-Catalyzed Azido-Alkyne Cycloaddition with EBTZ, 1 To a 5 mL SnapCap tube
was added 2 µL of a 50 mM CuSO4 solution in water, followed by 2 µL of a 50 mM
TCEP solution in water, then 2 µL of a 5 mM TBTA solution in DMSO, then 2 µL of a
100 mM solution of p-azidophenylalanine (pAzF) in water, and finally 40 µL of a 1 mM
solution of 1 in DMSO. All of this was diluted to 3 mL in deionized water. As a control, a
reaction between pAzF and 1 in the absence on the copper click catalyst system was
performed. A 1 fluorescent control was prepared by dissolving 40 µL of th solution of 1
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in 3 mL of deionized water. Finally, the effects of CuSO4 on inducing a turn on response
in 1 was performed by mixing 2 µL of the 50 mM CuSO4 solution with 40 µL of the
solution of 1. Fluorescnet profiles of all the 3 mL samples were taken in a quartz cuvette
by exciting at 285 nm and scanning from 310 to 510 nm with 8 nm excitation and
emission wavelength slits at a scan speed of 200 nm/min.
Organic Small Molecule Glaser-Hay with EBTZ, 1 To a flame dried vial and stir bar was
added ~10-20 mg of CuI, which was subsequently dissolved in 1 mL of pseudo-dry
tetrahydrofuran (THF). To this mix was added 60 µL of TMEDA and the catalyst system
was allowed to stir. Meanwhile, 100 µL of a 10 mM solution of 1 in DMSO (16 µg,
0.100 µmol) was added to the catalyst solution followed by 2 µL of the small molecule
partner (either propargyl alcohol or phenylacetylene at a >10 molar equivalency). This
reaction was allowed to stir at 60°C overnight. Following this, both reactions were
dissolved in an extra 1 mL of THF. Absorbancies were taken for both reactions using a
UV/Vis to verify the maximum absorption wavelength, which corresponded to the
maximum excitation wavelength.
Glaser-Hay with UAAs and EBTZ, 1 To a 3 mL SnapCap tube was added 2 µL of a 500
mM solution of CuI in water followed by 2 µL of a 500 mM solution of TMEDA. Next
was added 2 µL of an alkyne containing UAA (either p-propargyloxyphenylalanine or pethynylphenylalanine) and 40 µL of a 1 mM solution of 1 in DMSO. This mix was the
diluted to 3 mL using deionized water. Catalyst control reactions were set up by mixing
the UAAs and 1 as above without adding the CuI or TMEDA. These were allowed to
react overnight, and the 3 mL sample was then added to a quartz cuvette for fluorescence
analysis. Samples were excited at 328 nm and emission profiles were scanned for from
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350 to 550 nm using 8 nm excitation and emission wavelengths slits and a scan speed of
200 nm/min.
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